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ABSTRACT 
 
Molecular basis for H3.3/H4 deposition by the HIRA histone chaperone complex 
Michael Daniel Ricketts 
Ronen Marmorstein 
The HIRA histone chaperone complex is composed of the proteins HIRA, UBN1, and CABIN1 that 
cooperate with ASF1a to specifically mediate deposition of H3.3/H4 into chromatin. While many 
of the protein/protein contacts that allow for assembly of this multi-protein histone chaperone 
complex have been elucidated, how these proteins are able to cooperate to specifically bind and 
deposit H3.3/H4 over H3.1/H4, which differ by only 5 amino acids, has remained unclear. Here 
we demonstrate the HIRA complex subunit UBN1 specifically binds to H3.3/H4 over H3.1/H4 
using a combination of biochemical and structural studies. We show H3.3-specific binding is 
mediated by highly conserved residues in the UBN1 Hpc2-related domain (HRD) and residue G90 
in H3.3. Interestingly the UBN1 HRD and another H3.3-specific histone chaperone, Daxx, bind to 
H3.3/H4 in the region of G90 with striking similarity. Using sequence conservation and 
secondary structure prediction we have identified the UBN1 middle domain. We show the 
middle domain is able to form monomer and dimer populations as well as bind to H3/H4 
through interaction with the N-terminal histone tails. We have additionally discovered that a 
loop region linking the UBN1 HRD and middle domains binds non-specifically to DNA with 
nanomolar affinity, although UBN1 fragments containing the HRD, DNA binding loop, and 
middle domain are unable to bind assembled nucleosomes. Finally we demonstrate with 
analytical ultracentrifugation that the HIRA C-terminal domain forms a stable trimer and 
interacts with CABIN1 in a HIRA(3)/CABIN1(2) stoichiometry. We show that the HIRA C-terminal 
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domain is organized into separate strand and helical regions that must be linked for trimer 
formation. Further we show that a replisome protein called Ctf4 is structurally related to HIRA, 
as it also arranges into a trimer composed of separate strand and helical regions and interacts in 
a 3:2 stoichiometry with binding partners. From these observations we propose a model for 
H3.3/H4 deposition by the HIRA complex involving DNA binding and dimer formation by UBN1 
to mediate (H3.3/H4)2 tetramer formation organized on a HIRA(3)/UBN1(3)/CABIN1(2) complex 
where the third UBN1 molecule may harbor ASF1a/H3.3/H4 in reserve. 
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CHAPTER 1:  A molecular prospective for HIRA complex 
assembly and H3.3-specific histone chaperone function 
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1.1 – Introduction to the HIRA histone chaperone complex 
 
Incorporation of variant histone sequences, in addition to post-translational 
modification of histones, serves to modulate the chromatin environment. Different 
histone chaperone proteins mediate the storage and chromatin deposition of 
variant histones. Although the two non-centromeric histone H3 variants, H3.1 and 
H3.3, differ by only five amino acids, replacement of histone H3.1 with H3.3 can 
modulate transcription for highly expressed and developmentally required genes, 
lead to the formation of repressive heterochromatin, or aid in DNA and chromatin 
repair. The human HIRA complex composed of HIRA, UBN1, CABIN1 and 
transiently ASF1a, forms one of two complexes that binds and deposit H3.3/H4 
into chromatin. A number of recent biochemical and structural studies have 
revealed important details underlying how these proteins assemble and function 
together as a multi-protein H3.3-specific histone chaperone complex. Here we 
present a review of existing data and present a new model for assembly of the 
HIRA complex and for HIRA-mediated incorporation of H3.3/H4 into chromatin.  
About 3 billion base pairs of DNA are packaged into the nucleus of the majority of 
cells in the human body. To allow for the storage and regulation of this great 
length of genetic material the negatively charged DNA is compacted through 
binding to positively charged histone proteins for the formation of nucleosomes, 
the basic repeating units of chromatin(Kornberg, 1974; Olins and Olins, 1974). 
The nucleosome core particle is built from 147 base pairs of DNA wrapped 
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around an octamer of core histone proteins composed of two copies each of 
H2A, H2B, H3, and H4(Luger et al., 1997a; Luger et al., 1997b; Richmond and 
Davey, 2003). While the majority of nucleosomes are composed of canonical 
histones, there are also histones with variant amino acid sequences that are 
incorporated at specific regions of chromatin(Maze et al., 2014). Targeted 
incorporation of these variant histones(Maze et al., 2014) and post-translation 
modification to a variety of histone residues(Bannister and Kouzarides, 2011) are 
the two major ways that histones contribute to modulation and regulation of the 
chromatin environment to mediate distinct DNA-templated activities such as DNA 
repair, transcriptional regulation or DNA replication. 
Nucleosome assembly is coordinated by histone chaperone proteins, which bind 
specific histones to mediate their storage, eviction, or deposition from/or into 
chromatin(Burgess and Zhang, 2013; Laskey et al., 1978; Mattiroli et al., 2015). 
Histone chaperones are generally dedicated to binding and deposition of either 
the H3/H4 unit or the H2A/H2B unit although there are examples of proteins 
capable of chaperoning both H3/H4 and H2A/H2B(Tsunaka et al., 2016; Winkler 
et al., 2012). Some histone chaperons are able to bind several different variants 
of a particular histone, while others are dedicated to specifically binding just one 
variant sequence(Mattiroli et al., 2015).  The histone chaperone ASF1a binds to 
either H3.1/H4 and H3.3/H4 and associates with the CAF-1 complex for H3.1/H4 
deposition or the HIRA complex for H3.3/H4 deposition(Tagami et al., 2004; 
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Tang et al., 2006). Although H3.1 and H3.3 differ by only 5 amino acids, the 
HIRA complex specifically mediates replication-independent H3.3/H4 deposition, 
while the CAF-1 histone chaperone carries out H3.1/H4 deposition coupled to 
DNA replication and damage repair(Gaillard et al., 1996; Tagami et al., 2004).  
The HIRA complex is composed of the proteins HIRA, Ubinuclein-1 (UBN1), and 
CABIN1(Banumathy et al., 2009; Rai et al., 2011; Tagami et al., 2004). These 
three proteins function with ASF1a to mediate deposition of H3.3/H4 primarily at 
the bodies of actively transcribed genes(Goldberg et al., 2010; Pchelintsev et al., 
2013), gene regulatory regions(Banumathy et al., 2009; Jin et al., 2009; Rai et 
al., 2011), developmentally regulated genes(Banaszynski et al., 2013; Orsi et al., 
2013), and areas of DNA and chromatin damage and repair(Adam et al., 2013; 
Ray-Gallet et al., 2011; Schneiderman et al., 2012; Zhang et al., 2007). The 
ATRX/DAXX histone chaperone complex also binds specifically to H3.3/H4 but 
functions independently of ASF1a and the HIRA complex to deposit H3.3/H4 
mainly into areas of heterochromatin at telomeres, pericentromeres, and 
endogenous retroviral elements(Corpet et al., 2014; Elsaesser and Allis, 2010; 
Elsasser et al., 2012; Elsasser et al., 2015; Goldberg et al., 2010). While the 
HIRA and ATRX/DAXX complexes have largely separate functions, they employ 
similar structural features to bind H3.3/H4(Ricketts et al., 2015), both complexes 
may have some overlapping function in H3.3/H4 deposition during cellular 
senescence(Banumathy et al., 2009; Corpet et al., 2014; Rai et al., 2011; Ye et 
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al., 2007; Zhang et al., 2005), and ATRX/DAXX has been reported to deposit 
H3.3/H4 to activate gene transcription in neuronal cells. 
In recent years, a number of biochemical and structural studies have contributed 
to a greatly increased understanding of the molecular assembly and function of 
the HIRA histone chaperone complex. In this review, we focus on detailing these 
developments in order to present an updated model of HIRA complex assembly 
for H3.3-specific binding and deposition functions.  
1.2 – HIRA complex subunits 
 
The HIRA complex is assembled from HIRA, UBN1 and CABIN1 and coordinates 
with ASF1a to carry out H3.3-specific deposition. All three subunits and ASF1 
were identified and characterized individually before it was discovered that they 
work in concert to mediate deposition of H3.3/H4(Tagami et al., 2004). In this 
section we will review the known biological functions of the individual proteins 
that comprise the HIRA complex. 
ASF1a 
ASF1 (anti-silencing function 1) was originally identified in S. cerevisiae and 
named for the observed de-repression of silent mating type loci when 
overexpressed(Le et al., 1997). ASF1 was later characterized as a novel H3/H4 
binding protein involved in histone deposition during DNA replication and 
repair(Tyler et al., 1999). In human cells, ASF1 has two isoforms, ASF1a and 
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ASF1b(Tagami et al., 2004; Tang et al., 2006). ASF1a/b bind to both H3.1/H4 
and H3.3/H4 with similar affinity(Tagami et al., 2004). The CAF-1 complex 
cooperates with both ASF1a/b for H3.1/H4 deposition, while only ASF1a serves 
to deliver H3.3/H4 to the HIRA complex(Tagami et al., 2004; Tang et al., 2006; 
Zhang et al., 2005). Both HIRA and CAF-1 associate with the ASF1 N-terminal 
core using a small but conserved B-domain(Tang et al., 2006; Zhang et al., 
2005). ASF1a/b have also been shown to cooperate with MCM2 to coordinate 
H3/H4 deposition. While ASF1a and ASF1b are highly conserved in their N-
terminal core domains, they are divergent in their C-terminal tails; it has been 
shown that the C-terminal tail of ASF1b in combination with some region of HIRA 
outside the B-domain work together to inhibit HIRA binding, leading to a 
preferential association of HIRA with ASF1a(Tang et al., 2006).  
HIRA 
Human HIRA was identified within a genomic region lost in chromosome 22q11 
deletion syndrome (DiGeorge syndrome)(Lamour et al., 1995). Depletion of HIRA 
was initially thought to be a possible contributing factor to the symptoms 
observed in patients with DiGeroge syndrome(Lamour et al., 1995), although 
deletion of the Tbx1 gene was later identified as responsible for the symptoms of 
DiGeorge syndrome(Lindsay et al., 2001). Previous to the identification of HIRA 
within the 22q11 deletion, two S. cerevisiae proteins were identified as 
transcriptional regulators of the histone genes and named Hir1 and Hir2 for their 
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histone regulatory function(Sherwood et al., 1993; Spector and Osley, 1993). 
When the open reading frame in the 22q11 deletion was analyzed it was 
discovered that it was homologous to Hir1 and Hir2 and the protein was named 
HIRA. The histone chaperone function of HIRA was not discovered until later 
when the HIRA complex was purified from HeLa cells using a tagged H3.3 to pull 
down a complex containing ASF1a, HIRA, UBN1, and CABIN1(Tagami et al., 
2004). The transcriptional regulation of histone genes observed for S. cerevisiae 
Hir1/Hir2 has not been observed for human HIRA, although histone deposition by 
the HIRA complex has been linked to transcriptional activation for a number of 
highly expressed and developmentally regulated genes(Banaszynski et al., 2013; 
Dilg et al., 2016; Dutta et al., 2010; Goldberg et al., 2010). After the histone 
chaperone function of the human HIRA complex was characterized, S. cerevisiae 
Hir1/Hir2 were shown to form a complex with Hpc2 and Hir3, the S. cerevisiae 
orthologs of UBN1 and CABIN1, respectively, to carry out replication 
independent H3/H4 deposition(Green et al., 2005; Prochasson et al., 2005).  
UBN1 
UBN1 was originally identified as a ubiquitously expressed protein in the nuclei of 
human cells and shown to associate with endogenous and viral transcription 
factors to compete with binding to their DNA target sites(Aho et al., 2000; Aho et 
al., 2009). Although this transcription factor binding activity of human UBN1 is not 
well characterized at the biochemical level, the HIRA complex member CABIN1 
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has also been reported to bind a number of transcription factors(Hammond and 
Udvadia, 2010; Han et al., 2003; Jang et al., 2009; Liu et al., 2001; Youn and Liu, 
2000) so it is possible that the original observation was mediated through 
CABIN1. Similarly to HIRA, UBN1 was identified as a member of the HIRA 
complex when pulled down with H3.3. HIRA and UBN1 together appear to form a 
functional core of the HIRA complex as knock down, mutation, and depletion 
experiments suggest that both ASF1a and CABIN1 are dispensable for proper 
H3.3 deposition activity of the complex(Bonnefoy et al., 2007; Ray-Gallet et al., 
2007; Ray-Gallet et al., 2011; Song et al., 2013). Although the two proteins are 
weakly conserved, UBN1 was identified as an ortholog of the S. cerevisiae Hir 
complex subunit Hpc2 through alignment of the most conserved domain between 
the two proteins referred to as the Hpc2-related domain (HRD)(Banumathy et al., 
2009), or less commonly as the Hpc2-Ubinuclein-1 domain (HUN)(Balaji et al., 
2009). Recently UBN1 was shown to have H3.3-specific binding activity and 
likely mediates the specific deposition of H3.3/H4 over H3.1/H4 by the HIRA 
complex(Ricketts et al., 2015). 
CABIN1 
The largest member of the HIRA complex at 2220 amino acids, CABIN1, is 
predicted to have around thirty tetratricopeptide repeats (TPR)(Amin et al., 2013; 
Balaji et al., 2009). TPR domains are built from repeats of bi-helical pairs and 
often serve to mediate protein-protein interactions in large complexes(Blatch and 
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Lassle, 1999). Outside of binding to the C-terminal domain of HIRA(Rai et al., 
2011), the role of this TPR containing protein in the H3.3 deposition process 
remains unknown. Several functions of CABIN1 independent of the HIRA 
complex have been well studied. CABIN1 was identified as a binding partner of 
calcineurin and acts as a regulator of the calcineurin mediated signaling 
pathway(Song et al., 2013). CABIN1 has also been shown to physically 
associate with transcription factors p53(Jang et al., 2009) and MEF2(Esau et al., 
2001; Hammond and Udvadia, 2010; Han et al., 2003; Youn and Liu, 2000) to 
modulate their transcriptional regulatory activity. Further, modulation of MEF2 
activity by CABIN1 is also dependent on HIRA and ASF1a histone chaperone 
activity(Yang et al., 2011); so it is possible that the role of CABIN1 is to bind to 
these, and potentially other, transcription factors and recruit the HIRA complex to 
deposit H3.3/H4 at targeted areas of chromatin. This HIRA mediated H3.3/H4 
deposition may serve to modulate the local chromatin architecture and alter 
levels of transcription. Similar to CABIN1, the Hir3 S. cerevisiae ortholog of 
CABIN1 forms a complex with Hir1, Hir2, and Hpc2 to regulate transcription of 
histone genes and carry out replication independent histone deposition(Green et 
al., 2005; Prochasson et al., 2005; Spector and Osley, 1993).  
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1.3 – HIRA complex assembly and structure 
 
In recent years, several studies have focused on determining many of the key 
protein-protein contacts involved in assembly of the HIRA complex and its 
specific association with H3.3/H4 over H3.1/H4. Here we present a summary of 
current biochemical and structural data in an effort to describe the most accurate 
model of HIRA complex assembly and function as an H3.3-specific histone 
chaperone.  
HIRA as a molecular scaffold 
From several early studies, it became clear that the protein HIRA was the central 
member of this H3.3-specific histone chaperone complex.  The histone 
chaperone activity of HIRA was described independently of ASF1(Loppin et al., 
2005; Ray-Gallet et al., 2002), and its direct interaction and cooperation with 
ASF1a was identified shortly thereafter(Tagami et al., 2004; Tang et al., 2006; 
Zhang et al., 2005). The obvious functional significance of the HIRA protein in 
H3.3 deposition led to the current nomenclature of referring to the entire 
HIRA/UBN1/CABIN1 complex, and transiently ASF1a, as the HIRA complex. The 
undefined C-terminal domain of HIRA has been reported to bind H3/H4 with 
phosphorylation at H4S47(Kang et al., 2011), although this data has not been 
expanded upon and several other studies suggest that UBN1 may be responsible 
for the H3.3-specific binding and deposition by the HIRA complex(Banumathy et 
al., 2009; Ray-Gallet et al., 2011; Ricketts et al., 2015; Song et al., 2013). Most of 
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the existing data suggests that HIRA likely serves as a molecular scaffold for 
assembly of the complex, as it is known to directly associate with every other 
member of the HIRA complex (Figure 1.1). Interestingly the stability of the core 
HIRA/UBN1/CABIN1 complex is dependent on the presence of all three proteins, 
as knockdown or removal of any individual subunit results in severely decreased 
protein expression levels for the remaining subunits(Banumathy et al., 2009; Rai 
et al., 2011; Song et al., 2013).  
ASF1a/H3/H4 
Binding and deposition of H3/H4 by the ASF1 core domain has been extensively 
studied using biochemical and structural techniques35,42,58-60 (Figure 1.1). While 
there is less structural information for the ASF1a/H3/H4 complex(Agez et al., 
2007), the ASF1 core domain is so conserved that information from the S. 
cerevisiae structure is likely applicable to the human ASF1a system(Adkins and 
Tyler, 2004; English et al., 2006; English et al., 2005; Green et al., 2005; Tyler et 
al., 1999). It is clear that ASF1 binds to one H3/H4 dimer and has extensive 
contacts with H3/H4 along the (H3/H4)2 tetramer interface(English et al., 2006; 
English et al., 2005; Luger et al., 1997a; Natsume et al., 2007) (Figure 1.2a) thus 
inhibiting the formation of the (H3/H4)2 tetramer, which in the absence of ASF1 
exists in dynamic equilibrium with the H3/H4 dimer(Banks and Gloss, 2004; 
Winkler et al., 2012). ASF1a does not make any contacts to or near H3 residues  
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Figure 1.1 – Domain structures and interactions of HIRA complex members 
and H3.3/H4. (A) Domain structures of HIRA, UBN1, CABIN1 and ASF1a with 
arrows depicting all reported interactions between the complex members and 
H3.3/H4. (B) Proposed model for assembly of the HIRA complex based on the 
reported interacting domains.  
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Figure 1.2 – Structural basis for HIRA complex assembly and function. (A) 1.7 
Å crystal structure of S. cerevisiae Asf1 bound to X. laevis H3.1/H4 depicting the 
interaction of Asf1 with one H3/H4 dimer. (B) 2.7 Å crystal structure of the human 
HIRA/ASF1a complex showing association of the HIRA B-domain with the ASF1a 
core on the surface opposite to where ASF1a binds H3/H4. (C) 2.3 Å crystal 
structure of the UBN1/H3.3/H4/Asf1 complex revealing the molecular contacts 
between the UBN1 HRD and histone H3.3. (D) Structural model of the HIRA B-
domain superimposed onto the UBN1/H3.3/H4/Asf1 complex depicting a 
hypothetical intermediate in the pathway of HIRA-mediated H3.3/H4 deposition. 
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87-90, which are the major differentiating amino acids between H3.3 and H3.1, 
and is capable of supplying H3.1/H4 to the CAF-1 complex or H3.3/H4 to the 
HIRA complex(Tagami et al., 2004; Tang et al., 2006; Zhang et al., 2005). 
HIRA/ASF1a  
The interaction between ASF1a and HIRA was discovered upon the initial pull-
down of the HIRA complex form HeLa cells with tagged H3.3(Tagami et al., 
2004) and the HIRA B-domain spanning residues 439-475 was identified as the 
region responsible for contacting the ASF1a N-terminal core(Zhang et al., 2005) 
(Figure 1.1). The specific amino acid contacts between HIRA and ASF1a were 
then identified through determination of a 2.7 Å crystal structure of HIRA B-
domain residues 446-466 bound to the ASF1a core domain(Tang et al., 2006) 
(Figure 1.2b). Importantly the structure reveals that HIRA associates with the 
ASF1a core domain on the ASF1 surface opposite to where ASF1 binds the 
H3/H4 dimer, indicating that another domain of HIRA or member of the complex 
is likely capable of binding to H3.3/H4 on the outer surface, where the differing 
residues between H3.3 and H3.1 reside, to potentiate H3.3/H4 specific binding 
and chromatin deposition (Figure 1.2a,b). 
HIRA/UBN1 
The interaction between HIRA and UBN1 is essential for the stability of the HIRA 
complex as endogenous knockdown of UBN1 results in decreased HIRA 
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expression, and the same is observed for UBN1 expression when HIRA is 
knocked down(Banumathy et al., 2009). Additionally UBN1 is essential for H3.3-
specific deposition as depletion of UBN1 leads to decreased H3.3/H4 
incorporation into chromatin(Ray-Gallet et al., 2011). As the interaction between 
HIRA and UBN1 is essential for the stability and H3.3/H4 deposition function of 
the HIRA complex(Banumathy et al., 2009; Ray-Gallet et al., 2011), 
understanding the molecular basis the HIRA/UBN1 interaction is of great interest. 
It was initially reported that the N-terminal WD40 repeat domain in HIRA 
interacted with the HRD in UBN1(Banumathy et al., 2009). As the HRD is the 
most evolutionarily conserved domain in UBN1 this result initially made biological 
sense(Balaji et al., 2009; Banumathy et al., 2009). Although upon further 
biochemical dissection of the HIRA/UBN1 complex it was discovered that a 
weakly conserved domain slightly N-terminal to the HRD was essential for HIRA 
binding activity by UBN1, while the HRD was dispensable, this new UBN1 
domain N-terminal to the HRD was called the NHRD(Tang et al., 2012) (Figure 
1.1). 
HIRA/CABIN1 
CABIN1 was shown to be dispensable for H3.3/H4 deposition by the HIRA 
complex(Ray-Gallet et al., 2011), although similarly to UBN1, it appears to be 
important for the structural integrity of the HIRA complex. Depletion of 
endogenous CABIN1 levels in cells results in decreased expression of 
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endogenous HIRA, and depletion of HIRA has the same effect on CABIN1 
expression(Rai et al., 2011). Additionally, in the yeast Hir complex, removal of 
Hir1, Hir2 or Hpc2 results in decreased expression of Hir3(Song et al., 2013). 
Together these data suggest an important role for CABIN1 in the stability of the 
HIRA complex. While the entire 2220 amino acids of CABIN1 are spanned by 
about 30 TPR repeats(Amin et al., 2013), deletion experiments have mapped the 
N-terminal TPR segment of CABIN1, encompassing residues 1-941, as the 
minimal region required for HIRA binding(Rai et al., 2011) (Figure 1.1). Deletions 
probing HIRA have identified the structurally undefined C-terminal domain of 
HIRA composed from residues 736-963 as responsible for contacting 
CABIN1(Rai et al., 2011) (Figure 1.1). 
UBN1/H3.3/H4 
After the NHRD of UBN1 was identified as required for complex formation with 
the HIRA WD40 repeats, two studies implicated the more strongly conserved 
UBN1 HRD in H3.3-specific binding and chromatin deposition(Ricketts et al., 
2015; Song et al., 2013). Experiments probing function of the yeast Hir complex 
in H3.3-specific deposition in a human cell system showed that deletion of the 
HRD in Hpc2 abrogates H3.3/H4 deposition specificity(Song et al., 2013). 
Following this, a 2.3 Å crystal structure of UBN1 HRD residues 122-142 bound to 
H3.3/H4/Asf1 was determined and together with biochemical studies revealed 
that the highly conserved UBN1 HRD binds to H3.3 in the proximity of residues 
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87-90 to mediate specificity for binding to H3.3/H4 over H3.1/H4(Ricketts et al., 
2015) (Figure 1.2c). The crucial H3.3 residue for UBN1 binding specificity 
appears to be G90, as swapping M90 from H3.1 into H3.3 strongly decreases 
binding affinity(Ricketts et al., 2015).  
Structural model for the HIRA complex 
Based on the existing structural data for the HIRA sub-complexes of 
HIRA/ASF1a and UBN1/H3.3/H4/Asf1 we can infer a structural model where 
ASF1a associates with histones H3.3/H4 and delivers them to the HIRA complex 
for deposition through association of ASF1a with the HIRA B-domain, and 
H3.3/H4 with the UBN1 HRD (Figure 1.2d). As the order of assembly for the 
HIRA complex is not known, we propose that the UBN1 HRD binds to H3.3/H4 in 
complex with ASF1a at some point during ASF1a/HIRA complex formation. As 
the UBN1 HRD has greatly reduced binding affinity for H3.1/H4 in comparison 
with H3.3/H4(Ricketts et al., 2015), UBN1 likely functions to reject any 
ASF1a/H3.1/H4 complexes and ensure that only ASF1a bound to H3.3/H4 will be 
fully accepted for chromatin deposition by the HIRA complex. 
1.4 – Model for histone deposition by the HIRA complex 
 
A compilation of recent findings on HIRA complex assembly and H3.3-specific 
binding and deposition has led to our proposed structural model for the HIRA 
complex represented by a HIRA/UBN1/ASF1a/H3.3/H4 sub-complex (Figure 
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1.2d). While all existing data currently point to our proposed molecular assembly, 
this complex may represent an intermediate in the formation of the (H3/H4)2 
tetramer to be deposited into nucleosomes. ASF1a binds to a dimer of H3/H4 
along the tetramerization interface and prevents the formation of the (H3/H4)2 
tetramer(English et al., 2006). In the absence of ASF1, H3/H4 dimers exist in 
equilibrium with (H3/H4)2 tetramers(Banks and Gloss, 2004; Bowman et al., 
2010; Winkler et al., 2012) (Figure 1.3a). Stable isotope labeling with amino acids 
in cell culture (SILAC) mass spectrometry data indicates that the majority of 
H3/H4 is deposited into nucleosomes in the (H3/H4)2 tetramer form and tetramer 
splitting between nucleosomes is relatively rare(Xu et al., 2010) (Figure 1.3a).  
Many histone chaperones (CAF-1(Winkler et al., 2012), MCM2(Huang et al., 
2015; Richet et al., 2015), SPT2(Chen et al., 2015), Rtt106(Fazly et al., 2012), 
Vps75(Bowman et al., 2011), Nap1(Bowman et al., 2011), and SPT16(Tsunaka 
et al., 2016)) have been shown to stably bind an H3/H4 tetramer. MCM2 has 
been shown to associate with H3/H4/ASF1 or an (H3/H4)2 tetramer during DNA 
replication(Huang et al., 2015; Winkler et al., 2012), and similarly to the UBN1 
HRD, a loop of MCM2 interacts with the histone surface between the 1 and 2 
helices of H3(Huang et al., 2015; Ricketts et al., 2015). One molecule of MCM2 
is capable of binding to an H3/H4 dimer associated with ASF1 while two MCM2 
molecules can also bind to an (H3/H4)2 tetramer; indicating that MCM2 may act 
as an intermediate in the formation of (H3.1/H4)2 tetramers for deposition and  
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 Figure 1.3 – Model for incorporation of H3.3/H4 into nucleosomes by the HIRA 
complex. (A) In solution, histones H3/H4 exist in equilibrium between dimer and 
tetramer populations, although strong evidence suggests that they are deposited into 
the nucleosome in the tetramer form. (B) Model for HIRA complex mediated 
formation of an (H3.3/H4)2 tetramer prior to nucleosome deposition based on existing 
structural and biochemical data. The dotted lines represent presumed contacts 
lacking structural insight. 
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stabilization of (H3.1/H4)2 tetramers for recycling during DNA replication(Huang 
et al., 2015). Additionally, several studies indicate that the HIRA complex may be 
able to still deposit H3.3/H4 even in the absence of ASF1a(Bonnefoy et al., 2007; 
Ray-Gallet et al., 2007; Ray-Gallet et al., 2011). These data indicate that the 
ASF1a is likely not a permanent member of the complex and may serve to bind 
and protect H3.3/H4 before delivering them to the HIRA complex for tetramer 
formation and chromatin deposition. Based on these observations we propose a 
model for H3.3/H4 deposition by the HIRA complex where H3.3/H4/ASF1a 
associates with HIRA/UBN1/CABIN1 complex followed by eviction of ASF1a and 
UBN1-mediated formation of an (H3.3/H4)2 tetramer prior to deposition onto DNA 
(Figure 1.3b). 
Although crystallographic evidence shows that residues 122-148 of the UBN1 
HRD bound to an H3.3/H4 dimer in complex with ASF1(Ricketts et al., 2015), in 
solution ITC data in the absence of ASF1 indicates that fragments of UBN1 as 
large as 92-175 can bind an (H3.3/H4)2 tetramer with a stoichiometry of 2 
molecules or UBN1 to one (H3.3/H4)2 tetramer(Ricketts et al., 2015). As the 
UBN1 ITC experiments were conducted with H3/H4 concentrations where the 
histones should exist almost entirely in the tetramer form(Ricketts et al., 2015; 
Winkler et al., 2012), it can be concluded that the data represents two molecules 
of UBN1 associating with identical binding sites on one (H3.3/H4)2 tetramer. 
Considering both the ITC and crystallographic evidence, it seems possible that 
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UBN1 may function, similarly to MCM2, to bind H3/H4 dimers associated with 
ASF1 and mediate tetramer formation (Figure 1.3b). 
The molecular mechanism of how two UBN1 molecules cooperate to form the 
(H3.3/H4)2 tetramer is not known. Although there is no existing evidence for 
oligomerization of the human HIRA complex, the S. cerevisiae Hir complex has 
been reported to form an assembly of one copy each of Hir1 and Hir3 and two 
copies each of Hir2 and Hpc2(Prochasson et al., 2005). With two copies of the 
UBN1 ortholog Hpc2 found in the S. cerevisiae complex, it is possible that two 
HIRA complex molecules may come together for the formation of the (H3/H4)2 
tetramer (Figure 1.3b). 
Additionally, it is unclear if the HIRA complex cooperates with ATP-dependent 
chromatin remodelers to mediate deposition of H3.3/H4 onto DNA similarly to the 
complex formed by the histone chaperone DAXX and chromatin remodeler 
ATRX. It has been reported that the S. cerevisiae Hir complex likely functions to 
recruit the SWI/SNF complex to histone promoters(Dimova et al., 1999; 
Prochasson et al., 2005) but a direct interaction between the Hir and SWI/SNF 
complexes has not been conclusively shown. In mammalian cells the HIRA and 
CAF-1 complexes have been shown to work in concert with the chromatin 
remodeler INO80 during DNA double-strand break repair, although there is no 
evidence for complex formation as INO80 is essential for histone eviction during 
non-homologous end joining prior to nucleosome reassembly mediated by the 
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HIRA or CAF-1 complexes independent of INO80(Li and Tyler, 2016). While the 
possibility remains open, more comprehensive studies are needed to identify 
how the HIRA complex functions, whether alone or in complex with an ATP-
dependent chromatin remodeler. 
1.5 – Conclusion  
 
The HIRA complex is an evolutionarily conserved histone chaperone complex 
that operates to mediate H3.3-specific deposition in a wide variety of chromatin 
environments. While this review is not meant to be an exhaustive summary of 
HIRA complex biological function, a more comprehensive review is 
available(Amin et al., 2013) that features detailed analysis of the biological 
functions of the S. cerevisiae Hir complex and the HIRA complex in a number of 
species. Through summarizing the existing biochemical and structural data, this 
review has aimed to improve the current understanding of the architecture of the 
HIRA complex and to provide a testable model for H3.3-specific histone 
deposition by the complex.  Nonetheless, it is clear that our model would benefit 
from more structural information, and significant work still needs to be done to 
uncover the detailed molecular mechanism for the H3.3-specific histone 
chaperone function of the human HIRA complex. 
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CHAPTER 2: Ubinuclein-1 confers histone H3.3 binding specificity by the 
HIRA histone chaperone complex 
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2.1 – Overview 
 
Histone chaperones bind specific histones to mediate their storage, eviction or 
deposition from/or into chromatin. The HIRA histone chaperone complex, 
composed of HIRA, Ubinuclein-1 (UBN1), and CABIN1, cooperates with the 
histone chaperone ASF1a to mediate H3.3-specific binding and chromatin 
deposition. Here we demonstrate that the conserved UBN1 Hpc2-related domain 
(HRD) is a novel H3.3-specific binding domain. Biochemical and biophysical 
studies show the UBN1-HRD preferentially binds H3.3/H4 over H3.1/H4. X-ray 
crystallographic and mutational studies reveal that conserved residues within the 
UBN1-HRD and H3.3 G90 as key determinants of UBN1-H3.3 binding specificity. 
Comparison of the structure with the unrelated H3.3-specific chaperone DAXX 
reveals nearly identical points of contact between the chaperone and histone in 
the proximity of H3.3 G90, although the mechanism for H3.3 G90 recognition 
appears to be distinct.  This study points to UBN1 as the determinant of H3.3-
specific binding and deposition by the HIRA complex.  
In metazoan cells, there are two major H3 variants: H3.1 is deposited by the 
trimeric CAF-1 complex during DNA replication(Tagami et al., 2004) and repair of 
UV-induced DNA damage(Gaillard et al., 1996), while histone H3.3 is deposited 
in a replication-independent manner(Ahmad and Henikoff, 2002; Tagami et al., 
2004) by either DAXX/ATRX largely at heterochromatin, including 
pericentromeres, telomeres and endogenous retroviral elements (Elsaesser and 
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Allis, 2010; Elsasser et al., 2015; Goldberg et al., 2010; Wong et al., 2010), or by 
the HIRA complex predominantly at gene regulatory regions, gene bodies, 
developmentally regulated genes(Banaszynski et al., 2013; Banumathy et al., 
2009; Goldberg et al., 2010; Jin et al., 2009; Orsi et al., 2013; Pchelintsev et al., 
2013; Zhang et al., 2007), and sites of DNA and chromatin damage and repair 
(Adam et al., 2013; Ray-Gallet et al., 2011; Schneiderman et al., 2012; Zhang et 
al., 2007). However, DAXX/ATRX and HIRA likely also have some overlapping 
functions. For example, DAXX promotes H3.3 deposition at gene regulatory 
regions of activated neurons and both HIRA and DAXX are involved in H3.3 
deposition in non-proliferating senescent cells(Corpet et al., 2014). While the 
H3/H4 histone chaperone ASF1a interacts with both CAF-1 and HIRA complexes 
and binds to both H3.3/H4 and H3.1/H4 for histone deposition(English et al., 
2006; Galvani et al., 2008; Natsume et al., 2007; Tagami et al., 2004), CABIN1 
and UBN1 are unique members of the HIRA complex(Tagami et al., 2004).  
CABIN1 and UBN1 were initially identified as a negative regulator for calcineurin 
signaling in T lymphocytes(Sun et al., 1998) and as a ubiquitously expressed 
nuclear protein that interacts with cellular and viral transcription factors(Aho et 
al., 2000), respectively, and later shown to be functional members of the HIRA 
histone chaperone complex(Banumathy et al., 2009; Orsi et al., 2013; Rai et al., 
2011; Tagami et al., 2004).  
The human HIRA complex is orthologous to the S. cerevisiae Hir histone 
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chaperone complex, which regulates histone gene transcription(Sherwood et al., 
1993; Spector et al., 1997) and mediates replication-independent deposition of 
H3/H4 in yeast(Green et al., 2005). HIRA is homologous to Hir1 and Hir2(Lamour 
et al., 1995), CABIN1 is homologous to Hir3(Balaji et al., 2009; Rai et al., 2011; 
Tagami et al., 2004) and UBN1 is homologous to Hpc2 with strong sequence 
conservation in the HRD(Balaji et al., 2009; Banumathy et al., 2009). Although 
the UBN1-HRD was initially proposed to mediate association with the WD 
repeats of HIRA(Banumathy et al., 2009), we more recently demonstrated that a 
less conserved region of UBN1 that resides sixty residues N-terminal to the HRD 
is, in fact, responsible for HIRA-binding activity in UBN1; we named this domain 
the NHRD(Tang et al., 2012) (Figure 2.1a). These data in combination with the 
observations of others(Balaji et al., 2009) led us to the hypothesis that that the 
highly conserved UBN1-HRD may function to confer histone H3.3 binding 
specificity.  
The molecular basis for how the HIRA complex selectively binds to H3.3, which 
differs from H3.1 by only 5 amino acids, is unknown. In this study we report that 
H3.3-specific binding by the HIRA complex is mediated by the UBN1-HRD. We 
demonstrate that the UBN1-HRD specifically binds to H3.3/H4 over H3.1/H4 in a 
manner that is independent of the protein HIRA. Determination of a crystal 
structure containing a UBN1-HRD peptide bound to H3.3/H4/Asf1 and mutational 
studies aided us in identification of residues within the UBN1-HRD and H3.3 that 
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contribute to the specificity and strength of the UBN1/H3.3 interaction. 
Additionally the UBN1/H3.3/H4/Asf1 crystal structure reveals striking structural 
similarity between UBN1/H3.3/H4 and DAXX/H3.3/H4. Together, our results 
demonstrate that the UBN1-HRD mediates H3.3-specific binding by the HIRA 
complex and exemplify the evolutionary power of the H3.3 surface in 
encouraging the disparate histone chaperones UBN1 and DAXX to adopt similar 
structures.  
2.2 – A region of UBN1 containing the HRD specifically binds to H3.3  
 
We initially compared H3.3/H4 and H3.1/H4 binding activity of the HIRA(1-
405)/GST-UBN1(41-175) complex to that of GST-UBN1(92-175) (Figure 2.1b). 
HIRA(1-405) has predicted WD repeats and is the minimum UBN1-binding 
domain, UBN(41-175) has both the NHRD and HRD while UBN1(92-175) 
harbors only the HRD. GST-tagged proteins were incubated with H3.1/H4 or 
H3.3/H4 alone or in competition with the reciprocal His-H3/His-H4 (H3.1 or H3.3) 
complex and subjected to GST pull-down. We observed H3.3/H4 selective 
binding over H3.1/H4 for both HIRA(1-405)/GST-UBN1(41-175) and GST-UBN 
(92-175), indicating that a UBN1 HRD containing protein region can specifically 
bind H3.3 without contribution from HIRA (Figure 2.1b). In a control pull-down 
study, we demonstrated that GST-ASF1a binds to H3.1/H4 and H3.3/H4 with 
equal affinity while GST-UBN1(92-175) specifically binds to H3.3/H4 (Figure 2.2). 
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Figure 2.1 – A region of UBN1 containing the Hpc2-related domain (HRD) is 
able to specifically bind to histone H3.3. (a) Sequence alignment comparing two 
highly conserved domains in Homo sapiens UBN1, Drosophila melanogaster 
Yemanuclein, and Saccharomyces cerevisiae Hpc2. (b) GST pull-down histone 
binding assay. Binding to H3.3/H4 and H3.1/H4 is tested separately in a single input 
H3/H4 pull-down (left), and in competition by subjecting an equimolar mixture of 
H3/H4 and His-H3/His-H4 to pull-down (right). The H3.3-specific binding activity of 
GST-UBN1(41-175)/HIRA(1-405) (top), GST-UBN1(92-175) (middle), and free GST 
(bottom) is compared. (c) Isothermal titration calorimetry was used to quantitatively 
compare UBN1(92-175) binding to H3.3/H4 (left) and H3.1/H4 (right), +/- values 
represent the standard error of the ITC fit using Origin 7.0.  
 
 
 
43
 
Specificity for H3.3/H4 over H3.1/H4 was especially marked when UBN1 was 
presented with both H3/H4 variant complexes simultaneously. Specificity for H3.3 
was apparent in this assay regardless of whether H3.3 was His-tagged or 
untagged. Interaction of UBN1(92-175) with H3.3/H4 and H3.1/H4 was monitored 
Figure 2.2 – ASF1a control pull-down. UBN1(92-175) (right) is able to selectively 
bind H3.3/H4 while ASF1a FL (left) is not. Both chaperones are tested for binding to 
H3.1/H3 and H3.3/H4 alone as well as in competition with His-H3.1/His-H4. 
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directly with isothermal titration calorimetry (ITC) and indirectly through 
competition binding against a FITC-labeled UBN1 peptide (Figure 2.1c, Figure 
2.3d, Figure 2.5a). Both assays demonstrated that UBN1(92-175) binds to 
H3.3/H4 with a dissociation constant in the low micromolar range (~ 7-17 M 
depending on the assay used), while significant interaction with H3.1/H4 could 
not be detected with either assay (Figure 2.1c, Figure 2.3d). 
2.3 – Conserved HRD residues are required for binding to H3.3/H4  
 
UBN1 residues involved in the interaction with H3.3/H4 were investigated with an 
alanine scanning mutagenesis experiment targeted at the UBN1-HRD. A survey 
of the HRD was conducted by testing eighteen GST-UBN1(92-175) triple alanine 
mutants in the context of GST-UBN1(92-175), spanning residues 122-175, for 
their ability to pull-down with H3.3/H4 (Figure 2.4). The strongest ablation of 
binding was observed for mutants of UBN1 residues 135-142 (Figure 2.4) 
containing some of the most highly conserved residues of the HRD (Figure 2.1a, 
Figure 2.3). We then focused on this region by generating 27 alanine point 
mutations spanning UBN1 residues 122-148 (Figure 2.3a). UBN1 point mutants  
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Figure 2.3 – Conserved residues in the UBN1 HRD are required for binding with 
H3.3/H4. (a) Sequence alignment comparing HRD residues in Homo sapiens UBN1, 
Drosophila melanogaster Yemanuclein, and Saccharomyces cerevisiae Hpc2, strictly 
conserved residues are highlighted in red. (b) GST pull-down assay comparing the 
H3.3-binding activity of UBN1 wild-type and 27 alanine scanning point mutants (A144 
was mutated to I). (c) The IC50 for the binding with H3.3/H4 was quantified for each 
UBN1(92-175) variant using fluorescence polarization, +/- values represent the 
standard error of the curves fit using GraphPad Prism 5.0a. (d) Four representative 
fluorescence polarization histone-binding curves are shown error bars represent the 
s.e.m. of three independent replicates.  
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Figure 2.4 – Scanning alanine mutagenesis targeted at the UBN1 HRD. (a) A 
group of 18 triple alanine mutants were designed across the UBN1 HRD. (b) The gel 
representing a GST-pull down comparing the H3.3/H4 binding ability of the mutants to 
wild-type UBN1. 
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Figure 2.5 – Fluorescence polarization histone-binding assay. (a) FITC-
UBN1(127-148) fluorescence polarization binding curves with both H3.3/H3 and 
H3.1/H4. (b) A group of 27 alanine point mutants of UBN1 (92-175) were analyzed for 
binding to H3.3/H4 with a competition binding fluorescence polarization assay. Error 
bars represent the s.e.m. of three independent replicates, +/- values represent the 
standard error of the curves fit using GraphPad Prism 5.0a 
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were tested for interaction with H3.3/H4 using GST pull-down assays and 
fluorescence polarization histone-binding assays. Both experiments showed that 
the UBN1 Y132A, D133A, D136A, F138A, I139A, D140A, and N141A mutants 
exhibited reduced histone binding relative to wild-type UBN1 (Figures 2.3b-d, 
Figure 2.5). All of these residues are strictly conserved from yeast to human 
(Figure 2.3a), with the exception of N141 (which is sometimes conservatively 
substitute to a D). Alanine mutants of UBN1 residues 122-148 were additionally 
subjected to pull-down with H3.1/H4, and these mutants showed either no effect 
or a significantly smaller effect on UBN1 association with H3.1/H4, suggesting 
that the most conserved residues within the UBN1-HRD play a predominant role 
in H3.3 binding specificity (Figure 2.6).  
A minimal UBN1-HRD fragment, consisting of residues 122-148, was then 
investigated to determine if this conserved core region is sufficient for H3.3 
binding-specificity. In a pull-down assay GST-UBN1(122-148) exhibited 
specificity for binding to H3.3/H4 in comparison with H3.1/H4 (Figure 2.7b). ITC 
and FP histone-binding assays were employed to quantitatively confirm the H3.3-
specificity of the UBN1(122-148) peptide (Figure 2.7c, Figure 2.8b). While 
UBN1(122-148) maintains binding specificity for H3.3/H4 in comparison with 
H3.1/H4, UBN1(92-175) binds to H3.3/H4 about 3 to 6-fold more strongly than 
UBN1(122-148). This suggests that residues flanking 122-148 of the UBN1 HRD 
also contribute to H3.3-binding affinity. UBN1(92-148) and UBN1(122-175)  
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Figure 2.6 – GST pull-down to test the H3.1/H4 binding ability of alanine mutants 
of UBN1(92-175). 
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Figure 2.7 – H3.3 residue G90 mediates UBN1 specificity. (a) Sequence 
alignment comparing human histones H3.1 and H3.3 with the five amino acid 
differences highlighted in grey (b) GST pull-down assay comparing the ability of 
UBN1(122-148) to select between histone mutants where critical residues have been 
swapped between H3.1 and H3.3. UBN1 binding with wild-type H3.3/H4 and H3.1/H4 
was analyzed in addition to H3/H4 carrying several H3 mutants: H3.3(G90M), 
H3.1(M90G), H3.3(SAVM), and H3.1(AAIG). (c-h) Isothermal titration calorimetry 
quantification of the UBN1(122-148) interaction with wild-type and mutant H3/H4 
complexes. Dissociation constant (Kd) and stoichiometry of UBN1 binding to H3/H4 
are reported, +/- values represent the standard error of the ITC fit using Origin 7.0. 
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were analyzed for 
binding to H3.3/H4 
and H3.1/H4 with 
ITC to address the 
contributions of 
these flanking 
residues.  We found that both UBN1 fragments bind H3.3/H4 with similar 
dissociation constants (KD = ~14-16 M) while binding with H3.1/H4 was 
undetectable (Figure 2.8c).  This binding capacity is stronger than UBN1(122-
148) but weaker than UBN1(92-175), further suggesting that UBN1 residues 92-
121 and 149-175 contribute to the binding affinity of H3.3/H4.  
2.4 – H3.3 residue G90 mediates UBN1 specificity  
 
To establish the amino acids in H3.3 and H3.1 that confer specific binding of the 
former to UBN1-HRD, we analyzed the five residues that differ between H3.3 and 
H3.1 with a residue-swap mutagenesis experiment. The five differing residues 
are clustered in three patches along the sequence of H3 (S31A, SAVM87-
90AAIG and C96S) (Figure 2.7a, Figure 2.9a). We first tested H3.3(S31A), 
H3.3(SAVM) and H3.3(S96C) for binding to GST-UBN1(92-175) in pull down 
assays, in competition with wild-type His-H3.1/His-H4 (Figure 2.9b). Only the 
H3.3(SAVM) mutant abolished H3.3-specific binding from UBN1 (Figure 2.9b). 
Figure 2.8 – Different HRD-containing UBN1 constructs binding with both 
H3.3/H4 and H3.1/H4. (a) Sequence alignment comparing residues in Homo sapiens 
UBN1, Drosophila melanogaster Yemanuclein, and Saccharomyces cerevisiae Hpc2, 
strictly conserved residues are highlighted in red. (b) Fluorescence polarization 
competition binding assay to quantify the binding of UBN1(122-148) to both H3.3/H4 
and H3.1/H4. (c) Isothermal titration calorimetry was used to confirm that both UBN1 
(92-148) and (122-175) fragments specifically bind to an H3.3 containing H3/H4 
complex, +/- values represent the standard error of the ITC curves fit using Origin 7.0. 
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To assess the individual residue effects from this patch, H3.3 A87S, I89V and 
G90M mutants were applied in the same pull-down assays; only H3.3(G90M) 
prevented binding to UBN1 (Figure 2.9c). The reverse experiment, with H3.3 
residues introduced into H3.1, showed that the H3.1(M90G) mutant uniquely 
acquired binding to UBN1 (Figure 2.9d). GST-ASF1a FL and GST-UBN1(92-175) 
were  
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Figure 2.9 – Binding of UBN1 to H3.3 wild-type and mutants. (a) Sequence 
alignment highlighting the 5 differing residues between H3.3 and H3.1. Residues 
involved in pull-downs b, c and d are respectively underlined in yellow, red and blue. 
(b) GST pull-down indicating that the H3.3 residues AAIG mediate UBN1 specificity. 
(c) GST pull-down indicating that the H3.3 residue G90 is the crucial residue in the 
AAIG cluster responsible for UBN1 binding specificity. (d) Reverse GST pull-down 
experiment that shows that the lack of specificity in UBN1 for H3.1 can be rescued 
with a M90G mutant. 
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compared for selectivity between H3.3(SAVM) and H3.1(AAIG) mutants, and 
only GST-UBN1(92-175) exhibited binding specificity for H3.1(AAIG) (Figure 
2.9e). GST-UBN1(122-148) was analyzed for selectivity between the crucial 
histone residue-swap mutants and showed decreased binding to H3.3(SAVM) 
and H3.3(G90M), but increased binding to H3.1(AAIG) and H3.1(M90G) (Figure 
2.7b). A more quantitative analysis of the effect of H3.1 and H3.3 mutants on 
UBN1(122-148) binding was performed with ITC and demonstrated that the 
H3.3(G90M) and H3.3(SAVM) mutants had about a 3-fold decrease in 
UBN1(122-148) binding relative to H3.3 WT, and that the H3.1(M90G) and 
H3.1(AAIG) swap mutants bound UBN1(122-148) nearly as well as H3.3 WT 
(Figs. 2.7c). 
2.5 – UBN1/H3.3/H4/Asf1 structure reveals mode of H3.3 binding  
 
Having determined that the UBN1 HRD is necessary and sufficient for selective 
binding of H3.3 over H3.1 to better understand this at the molecular level, we set 
out to determine a crystal structure of the UBN1/H3.3 interaction. We were 
unable to obtain crystals of UBN1 in complex with H3.3/H4 alone. Previously a 
structure of the Asf1 core domain bound to H3.1/H4 lacking N-terminal tails was 
determined. We obtained this construct and modified it to generate a 
Asf1/H3.3/H4 complex that we successfully used for cocrystallization with a 
UBN1 peptide harboring the HRD region.  From those crystals we determined the 
2.3 Å X-ray crystal structure of a complex containing human UBN1(122-142) 
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bound to X. laevis H3.3(61-134), X. laevis H4(24-101), and S. cerevisiae Asf1(1-
154) (Figure 2.10a, Table 2.1). Not surprisingly, the Asf1/H3.3/H4 component of 
the structure superimposes perfectly with the previously reported Asf1/H3.1/H4 
structure (RMSD = 0.821 Å for all identical atoms) since the differences between 
H3.3 and H3.1 do not reside at the Asf1-histone interface. An omit map confirms 
electron density for UBN1 residues 122-142 (Figure 2.11). UBN1 residues 122-
127 form a short helix and residues 128-142 a coil, with the coil wrapping over a 
surface of H3.3 formed by helices 1 and 2 and the intervening turn. The UBN1 
helix (residues 122-127) projects away into solvent (Figure 2.10b). Confirming 
the biochemical studies, the UBN1 HRD makes intimate interactions with H3.3 
centered around G90 (Figure 2.10). The UBN1-H3.3 interface is nucleated by 
UBN1 residues F138 and Y132 that protrude into largely hydrophobic pockets on 
H3.3 and position the coil of residues 128-132 in a saddle that sits over the top of 
H3.3 G90 (Figure 2.10b). The hydroxyl group of UBN1 Y132 forms a hydrogen 
bond with the side chain of H3.3 Q93 (Figure 2.10c). The aromatic ring of UBN1 
Y132 makes extensive van der Waals interactions with the aliphatic side chain of 
H3.3 K64; a hydrogen bond with the UBN1 Y130 backbone carbonyl locks H3.3 
K64 into place above UBN1 Y132 (Figure 2.10c). A van der Waals interaction 
between the beta carbon of UBN1 D133 and the side chain of H3.3 L65 may also 
help anchor UBN1 Y132 into position (Figure 2.10c). UBN1 F138 sits in a 
hydrophobic pocket where it forms an extensive network of van der Waals  
 
 
57
 
 
 
Figure 2.10 – Crystal structure of the UBN1/H3.3/H4/Asf1 complex at 2.3 Å 
resolution. (a) Overall architecture of the UBN1/H3.3/H4/Asf1 complex with the 
position of H3.3 G90 highlighted in yellow. The structure is composed of UBN1 122-
148, H3.3 61-134, H4 24-102, and Asf1 1-154.  (b) UBN1 has an intimate association 
with the H3.3/H4 surface with close proximity to H3.3 G90 (yellow). UBN1 residues 
with sensitivity to alanine mutation are labeled. (c) Detailed stereo view of UBN1 
interactions with H3.3/H4.  
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Table 2.1. X-ray data collection and refinement statistics 
 
 
     
Table 1. X-ray data collection and refinement statistics  
 
Data collectiona 
    
Space Group 
 
P3221 
Cell Dimensions 
    
     a, b, c (Å) 
 
90.024, 90.024, 120.734 
      α, β, γ  (°) 
 
90.00, 90.00, 120.00 
Wavelength (Å) 
 
1.5418 
Resolution (Å) 
 
25.41 - 2.25 (2.33 - 2.25)b 
Rsym  
5.4 (44.0) 
I / σI  26.4 (2.7) 
Completeness (%) 
 
99.1 (93.3) 
Redundancy  
 
6.0 (3.8) 
Refinement statistics  
    
Resolution (Å) 
 
25.41 - 2.25 (2.33 - 2.25) 
No. reflections (total / unique) 
 
725,259 / 26,431 
Rwork/Rfree
 (%) 
 
20.82 / 23.48 
  
No. Atoms  
 
2866 
  
     Protein   
 
2692 
  
     Ligand/ion 
 
16 
  
     Water 
 
158 
  
B-factors (Å2) 
    
     Protein (Asf1/H3.3/H4) 
 
54.7 
  
     Protein (UBN1) 
 
67.2 
  
     Ligand/ion 
 
58.6 
  
     Water 
 
53.4 
  
R.m.s. deviations 
    
     Bong lengths (Å) 
 
0.003 
  
     Bond angles (°) 
 
0.637 
  
Ramachandran statistics 
    
     Favored (%) 
 
99.1 
  
     Allowed (%) 
 
0.90 
  
aOne crystal was used for data collection and refinement. 
 bValues in parentheses are for the highest resolution shell. 
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interactions with the aliphatic chain of H3.3 R72 and the aromatic ring of H3.3 
F84 ,as well as supporting interactions with H3.3 V71, A77 and I89 (Figure 
Figure 2.11 – Simulated annealing Fo - Fc omit map (contoured at 2σ) presented 
in stereo illustrating the high confidence of the UBN1 structural model. (a) Omit 
map was overlaid with the UBN1 structure (stick model) in the context of the bound 
H3.3/H4/Asf1 that is shown in surface representation in distinct colors. (b) View of the 
UBN1 omit map/structure overlay alone, with the same orientation as in (a) (top 
panel), or rotated 90 degree (bottom panel) for clarity of the various side chains. 
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2.10c). UBN1 I139 makes van der Waals interactions with the H3.3 I89 side 
chain and helps to cap the hydrophobic pocket in which UBN1 F138 binds 
(Figure 2.10c). UBN1 D136 and D140 form hydrogen bonds with H3.3 R72 and 
H4 T80 respectively, while the UBN1 N141 side chain makes hydrogen-bonding 
interactions with both the backbone amide and the side chain hydroxyl of H3.3 
S86 (Figure 2.10c). The backbone carbonyl from UBN1 F138 and backbone 
amide from UBN1 D140 form hydrogen bonds with the backbone amide and 
carbonyl from H3.3 F84 to further solidify the UBN1/H3.3 interaction (Figure 
2.10c). Notably, the structure reveals that evolutionarily conserved UBN1 
residues whose mutation disrupts H3.3 binding form hydrogen bond or van der 
Waals interaction with H3.3/H4 (Figure 2.10c). UBN1 residues that are not 
sensitive to mutation (E134, S135, and S137) do not make contact with H3.3/H4 
(Figure 2.12).  
2.6 – Asf1 and histones tails do not alter UBN1/H3.3 interaction 
 
To confirm the veracity of the interactions between UBN1 and H3.3/H4 observed 
in our crystal structure, we investigated how the presence of Asf1 in complex with 
H3/H4 affects the interaction between UBN1 and H3/H4. We conducted ITC to 
determine the affinity of UBN1(122-148) for complexes assembled with Asf1 and  
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Figure 2.12 – Detailed view of the UBN1/H3.3/H4 interaction including UBN1 
side chains E134, S135, and S137, which have no interaction with H3.3/H4. 
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FL H3/H4 or H3(60-135)/H4(20-102) lacking the N-terminal tails (Supplementary 
Figure9).  We found that UBN1(122-148) interacts with the Asf1/H3.3(FL)/H4(FL) 
complex with a dissociation constant (~49 M) comparable to that of UBN1(122-
148) binding to H3.3/H4 alone (~40-46 M depending on the assay) ; no 
significant interaction between UBN1(122-148) and Asf1/H3.1(FL)/H4(FL) was 
detected (Figure 2.13a). We then tested UBN1 (122-148) binding with 
Asf1/H3.3(60-135)/H4(20-102). The dissociation constant determined for this 
interaction (~110 M) is roughly 2 fold weaker than for UBN1(122-148) binding 
to the Asf1/H3.3(FL)/H4(FL) complex, although specificity for H3.3/H4 over 
H3.1/H4 was still evident (Figure 2.13b). These data suggest that the presence of 
Asf1 in complex with the histones does not significantly influence the binding and 
specificity of the UBN1-HRD for H3.3/H4 over H3.1/H4.  
2.7 – UBN1 and DAXX bind to H3.3/H4 with structural similarity 
 
A comparison of the structure reported here with the DAXX/H3.3/H4 
complex(Elsasser et al., 2012) reveals that while the histone chaperones UBN1 
and DAXX share no sequence conservation, they bind the region of H3.3/H4 
surrounding G90 with striking similarity (Figure 2.14 a-b, Table 2.2). The 
structural similarity between how UBN1 and DAXX bind H3.3/H4 is evident 
although the two chaperones have opposite orientations of N to C-terminal 
sequence when bound to H3.3/H4 and no conservation when aligned in either 
orientation (Figure 2.14 b). 
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Figure 2.13 – ITC analysis of UBN1 binding to Asf1/H3/H4 complexes 
containing FL and N-terminally truncated histones. (a) ITC analysis of 
UBN1(122-148) interaction with FL H3.3/H4 or FL H3.1/H4 in complex with Asf1(1-
169). (b) ITC analysis of UBN1(122-148) interaction with H3.3(60-135)/H4(20-102) 
or H3.1(60-135)/H4(20-102) in complex with Asf1(1-169), +/- values represent the 
standard error of the ITC curves fit using Origin 7.0. 
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Figure 2.14 – Comparison of UBN1 and Daxx interactions with H3.3/H4. (a) 
Detailed stereo view of DAXX interactions with H3.3/H4 showing conserved 
interaction surfaces. (b) Alignment of the UBN1/H3.3/H4/Asf1 and DAXX/H3.3/H4 
structures illustrating structural similarity between UBN1 and DAXX. (c) Surface 
representation of UBN1 shows that residues 128-132 rest closely over H3.3 G90 
(top) and would likely sterically occlude binding with H3.1 M90 (bottom). M90 is 
represented by substitution of G90 with the highest percentage methionine rotamer. 
(d) The same view of the DAXX/H3.3/H4 structure shows that DAXX has a cavity 
where UBN1 128-131 resides. The comparable DAXX site fills with water molecules 
to sterically occlude binding with H3.1/H4. 
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Table 2 
  
H3.3 Residue H4 Residue UBN1 Residue DAXX Residue  
K64   Y130, Y132 Y222, L223 
L65   D133 P218, L223 
R69   X D216 
V71   F138 L215 
R72   D136, F138 L212, L215 
A77   F138 L212 
F84   F138 L215 
S86   N141 E225 
I89   F138, I139 L210, L215 
 
T80 D140 E209 
F84 - S86* 
 
F138 - N141  K208 - L210 
    
*Backbone contacts are formed within this group of residues  
 
Table 2.2 – Comparison of Daxx and UBN1 residues 
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DAXX residues Y222, L210, and E209 are in essentially the same positions and 
mediate the same interactions as UBN1 residues Y132, I139 and D140, 
respectively (Figures 2.10c, 2.14a, and 2.15) In addition, L212 and L215 from 
DAXX maintain the same van der Waals interaction network that UBN1 F138 
forms with H3.3 (Figures 2.10c and 2.14a). Similar backbone interactions are 
also maintained between the DAXX and UBN1 chaperones with H3.3 (Figures 
2.10c, 2.14a). Table 2.2 summarizes the contacts that UBN1 and DAXX make 
with key H3.3/H4 residues.  
While DAXX and UBN1 contact H3.3/H4 in much the same way, they do not use 
the same mechanism to select for H3.3 over H3.1. UBN1 residues M128-Y132 sit 
in close proximity above H3.3 G90 (Figures 2.10b and 2.14c). A modeling of 
H3.3 G90M bound to UBN1 predicts that UBN1 would directly clash with a 
methionine at this position, suggesting that UBN1 employs a mechanism of steric 
occlusion to prevent unfavorable binding with H3.1 (Figure 2.14c). In contrast, 
the corresponding region within the DAXX/H3.3/H4 complex is solvent accessible 
and filled with a network of water molecules that are proposed to provide steric 
bulk to occlude binding with H3.124 (Figure 2.14d). Although G90 is the primary 
H3.3 residue responsible for UBN1 specificity other H3.3-specific residues may 
contribute to the UBN1 interaction. The delta carbon from H3.3 I89 forms a van 
der Waals interaction with UBN1 I139 and the H3.3 A87 beta carbon forms van  
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der Waals interactions with the beta and gamma carbons from UBN1 M128 
Figure 2.15 – Overlay of UBN1 and DAXX residues that contact the H3.3/H4 
surface with close proximity to H3.3G G90. H3.3 residues from the DAXX/H3.3/H4 
crystal structure that differ significantly from those in the UBN1/H3.3/H4/Asf1 
structure are shown in brown. 
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(Figure 2.10c).  Both of these residues are unique to H3.3 and may be 
responsible for the increased affinity that UBN1 has for the SAVM(87-90)AAIG 
mutation in H3.1 in comparison with a loan M90G mutation (Figure 2.7c). Taken 
together, while UBN1 and DAXX bind to the same region of histone H3.3, they 
achieve specificity for H3.3 over H3.1 by distinct mechanisms. 
2.8 – H3.3-specific binding occurs within HIRA/UBN1/CABIN1 complex 
 
To determine the contributions of the UBN1-HRD to H3.3 specificity in more 
complete HIRA and CABIN1-containing complexes, we prepared complexes 
containing full-length HIRA, UBN1 and CABIN1 proteins in wild-type form or 
bearing a UBN1 FID138-140AAA mutant, and assayed the ability of these 
complexes to pull down H3.3/H4 and H3.1/H4. This experiment demonstrated 
that HIRA/UBN1 and HIRA/UBN1/CABIN1 complexes assembled from full-length 
proteins preferentially bind to H3.3/H4 over H3.1/H4, and the preference is 
abolished in complexes containing the UBN1 FID138-140AAA mutant (Figure 
2.16).  
2.9 – Discussion 
 
Our data demonstrate that the UBN1 HRD is an evolutionarily conserved H3.3-
specific binding domain that exploits residue G90 in H3.3 to mediate specific 
binding and so deposition by the HIRA histone chaperone complex. Many studies  
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Figure 2.16 – UBN1-HRD/H3.3 interface is required for H.3.3 binding specificity in 
intact complexes. FLAG pull-down histone binding assay. Recombinant complexes of 
HIRA-FLAG(FL)/UBN1(FL) and HIRA-FLAG(FL)/UBN1(FL)/His-CABIN1(FL) with wild-
type and FID138-140AAA mutant UBN1 were analyzed for binding to both H3.3/H4 and 
H3.1/H4.  
 
 
 
70
have shown that HIRA complex specifically binds to and deposits H3.3 and is 
required for deposition of H3.3 at selected genomic regions (Banaszynski et al., 
2013; Corpet et al., 2014; Elsasser et al., 2015; Goldberg et al., 2010; Loppin et 
al., 2005; Tagami et al., 2004; Zhang et al., 2007). Our structural analysis shows 
this specificity for H3.3 comes primarily from HIRA-bound UBN1, not HIRA itself.  
The specificity of the UBN1 HRD for G90 may be evolutionarily conserved with 
the Hpc2 subunit of the yeast Hir complex. Recent data have shown that the 
yeast Hir complex can mediate H3.3-specific deposition when ectopically 
expressed in human cells and this specificity is dependent on the HRD in 
Hpc2(Song et al., 2013). In human cells, the UBN1 HRD functions to specifically 
bind H3.3 over H3.1 and presumably other variants containing M90 (H3.2, H3.4), 
and bulky L90 (CENP-A). H3.X, H3.Y and H3.5 represent primate-specific H3 
variants that also contain G90(Schenk et al., 2011; Wiedemann et al., 2010). Our 
data suggest that deposition of these H3 variants could also be coordinated by 
UBN1 (HIRA complex) or alternatively by DAXX.  
We show that the structures of the UBN1 and DAXX interactions with H3.3 have 
surprising similarity, although the two chaperones use different mechanisms to 
mediate H3.3 G90 specificity. The structures are broadly similar in the sense that 
both chaperones bind proximal to H3.3 G90 of H3.3/H4 with nearly identical 
molecular contacts. However, unlike the UBN1-HRD, DAXX wraps around the 
entire H3/H4 heterodimer to make more extensive histone contacts that likely 
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contribute to its enhanced general H3/H4 binding affinity relative to UBN1-HRD. 
Accordingly, it is possible that other UBN1 regions and/or other proteins within 
the HIRA complex also contribute to general histone binding affinity(Kang et al., 
2011; Lorain et al., 1998). In support of the participation of additional UBN1 
regions in H3/H4 binding is our observation that UBN1(92-175) binds H3.3/H4 
about 3 to 6-fold more strongly than UBN1(122-148) containing only the HRD 
(Supplementary Figs. 5b and 5c).  
With respect to G90 specificity, the steric bulk provided by UBN1 residues 128-
131 is perhaps more stringent than the water molecules that DAXX positions 
over G90. These water molecules can potentially be evacuated from the cavity to 
allow association with histone H3 variants with a bulkier amino acid at residue 
90. This idea was demonstrated by a crystal structure of 
DAXX/H3.3(G90M)/H4(Elsasser et al., 2012), and supported by a recent 
report(Lacoste et al., 2014) that DAXX can mediate promiscuous deposition of 
the H3 variant CENP-A that contains an L in the corresponding position 90 of H3.  
In addition, although we have demonstrated that UBN1 is primarily responsible 
for H3.3 binding specificity of the HIRA complex, the molecular basis for how the 
HIRA complex mediates deposition requires further studies. Our 
UBN1/H3.3/H4/Asf1 crystal structure may represent an intermediate in a 
potential hand off of histones between ASF1a/H3.3/H4 and HIRA/UBN1/CABIN1 
complexes prior to deposition into chromatin, as several studies suggest that 
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deposition function of the HIRA complex is not dependent on the presence of 
ASF1a(Bonnefoy et al., 2007; Ray-Gallet et al., 2007; Ray-Gallet et al., 2011). 
Nonetheless, the studies presented here provide important new molecular 
insights into how the HIRA histone chaperone complex specifically recognizes 
the histone H3.3 variant to regulate diverse genomic activities.  
2.10 – Materials and methods 
 
Multiple sequence alignments 
Multiple sequence alignments were generated using ClustalW2(Goujon et al., 
2010; Larkin et al., 2007). Alignments were further formatted for publication using 
ESPript version 3.0 to better visualize sequence conservation(Gouet et al., 
2003), with the exception of those in Figure 2.9a and supplementary Figure 2.7a 
which were manually formatted for publication. 
Expression and purification of GST-tagged proteins 
To generate the plasmid DNA construct encoding GST-UBN1(41-175), the cDNA 
encoding UBN1 residues 41-175 was PCR amplified from a previously discribed 
UBN1 construct (Banumathy et al., 2009) and ligated into the BamHI/XhoI sites 
of pFastBacGST (Invitrogen). The plasmid DNA construct encoding HIRA(1-405) 
was generated though PCR amplification and ligation of the cDNA endoding 
HIRA(1-405) into the BamHI/XhoI sites of pFastBacHTB (Invitrogen), removal of 
the 6xHistidine tag was facilitated through mutagenesis using the Stratagene 
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QuikChange protocol(Weiner and Costa, 1994). GST-UBN1(41-175) and 
HIRA(1-405) were co-expressed in baculovirus infected Sf9 cells. GST-ASF1a 
FL, GST-UBN1(92-175) and GST-UBN1(122-148) were generated though PCR 
by amplification of the proper cDNA sequence and ligation into the BamHI/XhoI 
sites of a custom engineered pCDFduet-1 (Novagen) Escherichia coli protein 
expression vector carrying an N-terminal GST tag that is removable through TEV 
protease cleavage. GST-UBN1(92-175) mutants were generated with the 
Stratagene QuikChange protocol(Weiner and Costa, 1994). GST-tagged proteins 
produced in Escherichia coli were induced with 0.8 mM IPTG added to BL21-
Gold(DE3) cells (Agilent) containing the desired expression plasmid and cells 
were grown overnight at 18°C. To purify GST-tagged proteins expressed in E. 
coli and Sf9, isolated cell pellets were suspended in 50 mL lysis buffer 
(phosphate buffered saline with 1 mM PMSF and 5 mM BME) per liter of cells 
and lysed with sonication. Lysate was clarified by centrifugation and the 
supernatant was incubated with glutathione agarose resin (Gold Biotechnology) 
for 1 hour prior to washing the resin with 60 column volumes of wash buffer 
(phosphate buffered saline with 5 mM BME). GST-tagged proteins were either 
eluted from the glutathione agarose with 5 column volumes of elution buffer 
(phosphate buffered saline with 5 mM BME and 20 mM reduced glutathione) or 
TEV protease was added to the protein-bound glutathione agarose and 
incubated overnight to cleave the target protein off the GST fusion. Eluted GST-
UBN1(92-175), GST-UBN1(122-148), GST-ASF1a and GST-UBN1(41-
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175)/HIRA(1-405) were then dialyzed overnight into buffer (20 mM Tris pH 8.0, 
25 mM NaCl, 5 mM BME) for ion exchange purification using a HiTrap™ Q HP 
column (GE Healthcare). Protein released from GST by TEV cleavage was 
eluted with 6 column volumes of buffer (Hepes pH 7.5, 750 mM, 1 mM TCEP) 
and concentrated using a 3K cutoff centrifugal filter device (Millipore) prior to a 
final gel filtration purification step with a Superdex S75 10/300 GL column (GE 
Healthcare).  
Expression and purification of recombinant H3/H4 
Human histones H3.3 and H3.2 were amplified by PCR from a human cDNA 
library (ATCC 77430) and ligated into the BamHI/XhoI sites of a custom 
engineered pETduet-1 (Novagen) Escherichia coli protein expression vector with 
an N-terminal 6xHistidine tag that is removable through TEV protease cleavage. 
A construct to express the amino acid sequence for H3.1 was generated by site-
directed mutagenesis of H3.2. Human histone H4 has a sequence that carries 
several rare codons which are not conducive to expression in Escherichia coli 
and to overcome this issue we obtained a previously described codon-optimized 
construct encoding H4 from X. laevis which has the same amino acid sequence 
as human H4(Luger et al., 1997b). The codon-optimized X. laevis H4 cDNA was 
PCR amplified and ligated into the BamHI/XhoI sites of the same Escherichia coli 
protein expression vector as the H3 constructs. H3 and H4 proteins were 
expressed as inclusion bodies in BL21-Gold(DE3) cells (Agilent) induced with 0.8 
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mM IPTG, protein was expressed for 4 hours at 37°C. To purify H3 and H4 cells 
were lysed with sonication in 50 mL of lysis buffer (20 mM Tris pH 7.5, 500 mM 
NaCl, 5 mM BME) per liter of cells, lysate was clarified with centrifugation.  Cell 
pellets containing insoluble H3 or H4 were then resuspended in denaturing buffer 
(20 mM Tris pH 7.5, 500 mM NaCl, 7.0 M GdHCl, 5 mM BME) and clarified with 
centrifugation.  Denatured H3 or H4 were incubated with Ni-NTA agarose resin 
for 1 hour prior to washing the resin with 60 column volumes of denaturing buffer. 
Proteins were either eluted from the Ni-NTA agarose with 5 column volumes of 
elution buffer (300 mM Imidazole, 20 mM Tris pH 7.5, 500 mM NaCL, 7.0 M 
GdHCl, 5 mM BME).  Eluted proteins were the dialyzed into water and 
lyophilized.  Refolding was conduced through resuspending the lyophilized H3 
and H4 in denaturing buffer and mixing the two histones at 1:1 prior to refolding 
by dialysis against two changes of non-denaturing buffer (20 mM Tris pH 7.5, 1.0 
M NaCl, 5 mM BME, 1 mM EDTA) followed by dialysis into a low salt buffer (20 
mM Tris pH 7.5, 100 mM NaCl, 5 mM BME, 1 mM EDTA) prior to ion exchange 
purification using a HiTrap™ SP HP column (GE Healthcare). The 6xHistidine 
tags on H3 and H4 were either left on the protein or removed by treatment with 
TEV protease during the refolding reaction. Following ion exchange the refolded 
H3/H4 complexes were further purified with gel filtration using a Superdex 200 
10/300 GL column (GE Healthcare). H3.3 and H3.1 residue-swap point mutants 
were generated using the Stratagene QuikChange protocol(Weiner and Costa, 
1994). 
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Synthetic petides 
Large scale peptide synthesis of UBN1(122-148) and FITC-UBN1(127-148) was 
commissioned by a commercial vendor (Genscript).  
GST pull-down histone binding assay 
GST-tagged UBN1 proteins and H3/H4 complexes were prepared as described 
above. The pull-down experiments represented in Figure 2.1 and Figure 2.2 were 
conducted by incubating 2 µM GST-tagged protein with 2 µM H3/H4 (or 2 µM 
H3/H4 in competition with 2 µM His-H3/His-H4) in a buffer containing 20 mM 
Hepes pH 7.5, 500 mM NaCl, and 1 mM TCEP at 4°C for 30 minutes. Proteins 
were then subjected to pull-down by incubation with glutathione agarose resin 
(Gold Biotechnology) for 30 minutes. Resin was washed with 120 column 
volumes of buffer (20 mM Hepes pH 7.5, 500 mM NaCl, and 1 mM TCEP) prior 
to elution of bound proteins by boiling resin in SDS gel-loading buffer. All other 
GST pull-down experiments were conducted by incubating 2 µM GST-tagged 
protein with 4 µM H3/H4 (or 4 µM H3/H4 in competition with 4 µM His-H3/His-H4) 
in a buffer containing 20 mM Hepes pH 7.5, 750 mM NaCl, and 1 mM TCEP at 
4°C for 30 minutes. Proteins were then subjected to pull-down by incubation with 
glutathione agarose resin (Gold Biotechnology) for 30 minutes. Resin was 
washed with 120 column volumes of buffer (20 mM Hepes pH 7.5, 750 mM NaCl, 
and 1 mM TCEP) prior to elution of bound proteins by boiling resin in SDS gel-
loading buffer. Results of the pull-down assays were analyzed though 
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visualization of input and pull-down samples with SDS-polyacrylamide gel 
electrophoresis. Gels were stained using Coomassie Brilliant Blue G-250.  
Isothermal titration calorimetry  
Quantitative analysis of the UBN1/histone interaction was conducted with a VP-
ITC microcalorimeter (MicroCal). All proteins/peptides were prepared in a buffer 
with 20 mM Hepes pH 7.5, 750 mM NaCl and 1 mM TCEP prior to ITC analysis. 
Experiments for Figures 2.1c and 2.7c were conduced by injecting 0.450 mM 
UBN1 into a calorimetry cell containing 30 µM H3/H4, where UBN1 was injected 
in 7 µL increments every 3 minutes at 22°C and ITC reference power set to 30. 
Experiments for supplementary figure 5c were conducted with the same cell and 
syringe concentrations but UBN1 was injected in 10 uL increments every 3 
minutes at 22°C and ITC reference power was set to 20. Data were analyzed 
using Origin version 7.0 and corrected for heat of mixing and dilution.  
Fluorescence polarization histone-binding assay  
Quantitative analysis of the UBN1/histone interaction was conducted with a FP-
based competition-binding assay; all data were collected using a PerkinElmer 
EnVision Xcite Multilabel plate reader. All proteins and peptides for this assay 
were prepared in a buffer containing 20 mM Hepes pH 7.5, 750 mM NaCl and 
1mM TCEP. We commissioned commercial synthesis of a UBN1(127-148) 
peptide with an N-terminal FITC moiety (Genscript). The Kd of FITC-UBN1(127-
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148) for binding to H3.3/H4 (Kd = 4.3 ± 0.2 µM) and H3.1/H4 (Kd = 17.7 ± 2.3 µM) 
was measured by monitoring the change in fluorescence polarization when 
increasing H3/H4 is titrated into a constant concentration of FITC-UBN1(127-
148) (10 nM) (Figure 2.5a). The curves were fit using a one site – total binding 
model with GraphPad Prism (version 5.0a) 
(Y=Bmax*X/(Kd+X) + NS*X + Background). We found that the FITC moiety or 
linker used to attach it to UBN1 artificially enhances the UBN1/histone interaction 
in comparison with both UBN1(92-175) and UBN1(122-148) (Figure 2.5a). 
Despite this, we were still able to use FITC-UBN1(127-148) for a competition-
binding assay. To obtain a suitable fluorescence polarization range in the 
competition binding assay, the concentration of H3/H4 was held at or slightly 
above the relative dissociation constant for FITC-UBN1(127-148). Increasing 
concentration of UBN1 competitor was titrated into solutions containing constant 
concentrations of FITC-UBN1(127-148) (10 nM) and either H3.3/H4 (6.5 µM) or 
H3.1/H4 (25 µM) to estimate IC50 values by competition binding. UBN1 wild-type 
and all 27 point mutants were also titrated into a solution containing only the 
FITC-UBN1(127-148) to generate curves used to subtract background 
polarization, which is possibly caused by UBN1 self-association. Curves for 
D136A, S137A, F138A, I139A, and D140A had a slightly different scale in 
comparison with others and were normalized to the average baseline; 
normalization did not alter data interpretation. Competition binding curves were fit 
using the one site – total binding model with GraphPad Prism (version 5.0a). 
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Recombinant H3/H4 are known to form a strong (H3/H4)2 homotetramer at 
concentrations above 1 µM(Winkler et al., 2012). Due to this H3/H4 
conformation, two molecules of UBN1 are necessary to completely compete both 
FITC-UBN1 molecules away from the histone tetramer. Taking the binding 
stoichiometry of (UBN1)2/(H3/H4)2 into account, the concentration of UBN1 
reported in the fluorescence polarization titration curves actually represents half 
of the molecular concentration of UBN1. 
Crystallization and structure determination 
We obtained as a generous gift from Mair Churchill (University of Colorado 
School of Medicine) the GST-Asf1/H3.1/H4 polycistronic Escherichia coli co-
expression construct that was previously used to produce Asf1/H3.1/H4 for 
crystallization and structure determination(English et al., 2006). We used 
mutagenesis(Weiner and Costa, 1994) to generate a construct encoding 
Asf1/H3.3/H4 for our purposes. The GST-Asf1/H3/H4 complex was expressed in 
BL21-Gold(DE3) cells (Agilent) induced with 0.8 mM IPTG, protein was 
expressed for 8 hours at 28 °C.  Cell pellets were resuspended in 50 mL of lysis 
buffer (20 mM Tris pH 8.0, 500 mM NaCl, 1 mM PMSF, 5 mM BME) per liter of 
cells and lysed with sonication. Lysate was clarified by centrifugation and the 
supernatant was incubated with glutathione agarose resin (Gold Biotechnology) 
for 1 hour prior to washing the resin with 60 column volumes of wash buffer (20 
mM Tris pH 8.0, 500 mM NaCl, 5 mM BME). The Asf1/H3/H4 complex was then 
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released from the resin with on-column cleavage using prescission protease. The 
cleaved Asf1/H3/H4 complex was eluted with 6 column volumes of elution buffer 
(20 mM Tris pH 8.0, 500 mM NaCl, 1 mM TCEP).  The free Asf1/H3/H4 complex 
was then concentrated using a 3K cutoff centrifugal filter device (Millipore) prior 
to a final gel filtration purification step with a HiLoad 16/600 Superdex S75 pg 
column (GE Healthcare). The UBN1(122-148)/Asf1/H3.3/H4 complex was formed 
by incubating 0.2 mM Asf1/H3.3/H4 with 0.8 mM UBN1(122-148) in a buffer 
containing 20 mM Tris pH 8.0, 500 mM NaCl and 1 mM TCEP prior to 
crystallization. Hanging drops for vapor diffusion were formed by mixing two 
volumes of protein solution with one volume of crystallization solution (0.1 M 
Sodium Cacodylate pH 6.0, 8% PEG 8K, 0.2 M NaCl) and crystals appeared 
within 48 hours. X-ray diffraction data were collected using an in-house Rigaku 
MicroMax-007HF microfocus rotating anode x-ray generator and a Saturn 944+ 
CCD detector. The diffraction data were indexed and scaled using HLK3000, and 
a Molecular Replacement solution was obtained using Phaser in the Phenix 
software suite with Asf1/H3.1/H4 (PDB ID, 2HUE) used as a search model. The 
solution was refined using phenix.refine in the Phenix software suite and model 
building was carried out using the molecular-graphics program Coot. The solution 
model contains UBN1(122-142), H3.3(61-134), H4(24-102), and Asf1(1-154). 
Electron density was not observed for Asf1 residues 155-169, H3.3 residue 60, 
and H4 residues 19-23. Table 2.1 shows a summary of the refinement statistics. 
Simulated annealing Fo - Fc omit map for the UBN1 peptide was generated using 
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phenix.refine in the Phenix software suite. Figures for publication were generated 
using the program PyMOL. Structure comparison of UBN1 and DAXX were 
carried out using the published crystal structures of DAXX/H3.3/H4 (PDB ID, 
4H9N) and DAXX/H3.3(G90M)/H4 (PDB ID, 4H9O)(Elsasser et al., 2012). 
Assembly of Asf1/H3(FL)/H4(FL) complexes 
As described previously(English et al., 2005), expression and purification of the 
heterotrimeric Asf1(1-169)/H3(60-135)/H4(20-102) complex from Escherichia coli 
yields a large excess of Asf1 not in complex with H3/H4 that can be separated 
from the Asf1/H3/H4 complex on a HiLoad 16/600 Superdex S75 pg column (GE 
Healthcare). We collected this excess Asf1 to be used for complex formation with 
either FL H3.3/H4 or FL H3.1/H4. Complexes were formed through mixing a 2-
fold excess of Asf1 with H3.3/H4 or H3.1/H4 in a buffer containing 20 mM Hepes 
pH 7.5, 2.0 M NaCl, and 1 mM TCEP, this mixture was then dialyzed overnight 
into a buffer containing 20 mM Hepes pH 7.5, 750 mM NaCl, and 1 mM TCEP.  
The mixture was then injected onto a HiLoad 16/600 Superdex S75 pg column 
(GE Healthcare) to separate the Asf1/H3/H4 complex from the excess Asf1. The 
resulting Asf1/H3/H4 was used for ITC studies.  
pFastBacDual HIRA/UBN1 
A C-terminally FLAG tagged open reading frame of full-length human HIRA 
encoded by nucleotides 221 to 3271 of NM_003325 were PCR amplified and 
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subcloned into the XmaI and SphI restriction sites 3’ to the P10 promoter in 
pFastBacDual. Nucleotides 843 to 4247 of NM_016936 encoding full-length 
human UBN1 were PCR amplified and subcloned into the SalI and XbaI 
restriction sites 3’ to the PH promoter in pFastBacDual. The FID(138-140)AAA 
mutation was introduced into UBN1 in the pFastBacDual vector by the 
Stratagene QuikChange protocol(Weiner and Costa, 1994). 
Expression of recombinant proteins in insect cells 
Sequence-confirmed pFastBac transfer vectors containing sequences for human 
HIRA, UBN1 and CABIN1 were transformed into DH10Bac cells. Proper 
recombination of the HIRA, UBN1 and CABIN1 sequences into the baculovirus 
genome was determined by PCR and positive bacmid DNAs were transfected 
into Sf9 cells(Gillette et al., 2011). High-titer passage 1 (P1) virus stocks were 
recovered 120 hours post-transfection. A high-titer P2 virus stock was generated 
by infecting Sf9 at an MOI (Multiplicity Of Infection) of ~0.1, followed by 
incubation for 120 hours. For productions, 1 x 106 Sf9 cells/ml in Sf900-III 
medium (Invitrogen) were infected with virus at an MOI of 1. Infected cells were 
harvested 48 hours post-infection. 
Histone pull-downs with the intact HIRA/UBN1/CABIN1 complex 
The HIRA-FLAG/UBN1 and HIRA-FLAG/UBN1/His-CABIN1 complexes 
containing wild-type UBN1 or UBN1(FID138-140AAA) mutant was purified by 
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suspending isolated cell pellets in 50 mL lysis buffer (20 mM Tris pH 8.0, 500 mM 
NaCl, 1 mM PMSF, 1 mM BME and a complete EDTA-free protease inhibitor 
tablet (Roche)) per liter of cells, and lyses with sonication. Lysate was clarified by 
centrifugation and the supernatant was incubated with ANTI-FLAG M2 affinity gel 
(Sigma-Aldrich) for 2 hours prior to washing the gel with 60 column volumes of 
wash buffer (20 mM Tris pH 8.0, 500 mM NaCl, 1 mM BME).  The FLAG gel was 
bound to capacity for both the wild-type and mutant complexes.  To conduct the 
FLAG pull-down assay, 50 L of bound gel was incubated for 30 minutes with 4 
µM H3/H4 in a buffer with 20 mM Tris pH 8.0, 750 mM NaCl and 1 mM BME. 
Then the gel was washed with 120 column volumes of buffer (20 mM Tris pH 8.0, 
750 mM NaCl, and 1 mM BME) prior to elution of bound proteins by boiling the 
gel in SDS gel-loading buffer. Results of the pull-down assays were analyzed 
though visualization of input and pull-down samples with SDS-polyacrylamide gel 
electrophoresis. Gels were stained using Coomassie Brilliant Blue G-250.  
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CHAPTER 3:  The HIRA histone chaperone complex subunit UBN1 harbors 
H3/H4 and DNA binding activity 
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3.1 – Overview 
 
The deposition of histones onto DNA for nucleosome formation and chromatin 
maintenance is a hallmark of eukaryotic cells and serves to package and protect 
DNA for the efficient regulation of gene expression. Histone deposition is 
coordinated by histone chaperone proteins, which serve to bind and protect the 
basic histone proteins from non-specific interactions prior to deposition into 
nucleosomes (Burgess and Zhang, 2013; Laskey et al., 1978). Additionally, 
histones have many variant sequences that are incorporated into nucleosomes at 
specific genomic locations to effect changes on the local chromatin environment, 
and many distinct histone chaperones have specifically evolved to bind and 
deposit a single variant histone into chromatin (Mattiroli et al., 2015; Maze et al., 
2014). The human HIRA histone chaperone complex specifically binds to and 
deposits H3.3/H4 into chromatin in a replication-independent manner (Tagami et 
al., 2004). The complex is composed of the three core subunits, HIRA, UBN1, 
and CABIN1, with the transient addition of ASF1a, which serves to bring an 
H3.3/H4 dimer to the complex but is not required for ultimate H3.3/H4 deposition 
into nucleosomes (Bonnefoy et al., 2007; Ray-Gallet et al., 2007; Tagami et al., 
2004). Much work has been done to elucidate how the HIRA complex assembles 
(Banumathy et al., 2009; Rai et al., 2011; Tang et al., 2006; Tang et al., 2012), 
and we have recently reported that UBN1 specifically binds an H3.3/H4 dimer 
bound to ASF1a (Ricketts et al., 2015); but the mechanism of how the HIRA 
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complex ejects ASF1a and transitions the H3/H4 dimer to an (H3.3/H4)2 tetramer 
for deposition is not clear. The study of (H3/H4)2 tetramer deposition has been 
the focus of work for several other histone chaperones system (Chen et al., 
2015; Huang et al., 2015; Mattiroli et al., 2017; Richet et al., 2015; Sauer et al., 
2017; Wang et al., 2015; Zasadzinska et al., 2013) since the discovery that the 
vast majority of H3/H4 is deposited onto DNA in the tetramer form for eventual 
nucleosome formation upon the addition of two H2A/H2B dimers (Xu et al., 
2010). 
The HIRA complex subunit UBN1 has been reported to bind to the WD40 domain 
of HIRA though a small domain of about 30 amino acids called the NHRD (Tang 
et al., 2012), named after discovery of it’s HIRA binding activity because it lies 
just N-terminal to a strongly conserved UBN1 domain called the Hpc2-related 
domain (HRD), named for it’s conservation with Hpc2, the S. cerevisiae homolog 
of UBN1. After identification of the NHRD as a HIRA-binding domain we were 
able to show that the HRD specifically binds to H3.3/H4 and determined a crystal 
structure of the UBN1/H3.3/H4/Asf1 complex (Ricketts et al., 2015). While, the 
crystal structure is informative about the exact nature of the H3.3-specific 
interactions that are mediated by UBN1, it only contains 20 amino acids from 
UBN1. So with roughly 50 amino acids from UBN1 being well characterized for 
function out of 1134 residues, we decided to attempt to characterize additional 
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regions of UBN1 to identify previously unknown functions to potentially learn 
more about how the HIRA complex binds and deposits H3.3/H4 into chromatin. 
Here we characterize two UBN1 domains of previously unknown function. 
Through secondary structure prediction and sequence conservation we have 
identified a roughly centrally located region of UBN1, which we call the UBN1 
middle domain, spanning residues ~300-600, predicted to have helical secondary 
structure. Though size-exclusion chromatography and analytical 
ultracentrifugation experiments we have shown that the C-terminal region of the 
UBN1 middle domain, residues 504-584, are responsible for dimer formation. 
Through pull-down and deletion analysis we have also shown that the N-terminal 
region of the UBN1 middle domain, residues 296-341, is required for H3/H4 
binding. Additionally we have identified several vertebrate-specific conserved 
lysine residues in a very basic loop region of low predicted structure residing 
between the UBN1 HRD and middle domain. Using fluorescence polarization and 
size-exclusion chromatography analysis of UBN1/DNA complex formation we 
have determined that these conserved lysine residues are essential for non-
specific DNA binding by UBN1. Together, our observations of H3/H4 binding and 
dimer formation by the UBN1 middle domain indicate that UBN1 may be capable 
of binding two H3.3/H4 molecules to induce (H3.3/H4)2 tetramer formation in a 
pathway to nucleosome deposition that may also involve UBN1-mediated DNA 
binding by the HIRA complex.    
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3.2 – The UBN1 middle domain forms stable monomer and dimer 
populations 
To identify regions of UBN1 that contribute to the biological function of the human 
HIRA histone chaperone complex, beyond the well characterized HRD and 
NHRD domains, we performed a multiple sequence alignment of metazoan 
UBN1 homologs to hone in on additional regions of conservation to probe for 
functional significance (Figure 3.1). Hpc2, the UBN1 homolog from S. cerevisiae, 
only shares conservation in the HRD and NHRD domains, to identify nuanced 
features of human UBN1 outside of these domains we omitted UBN1 homologs 
from yeast from our alignment. Through alignment of Homo sapiens UBN1, Mus 
musculus UBN1, Gallus gallus UBN1, Scleropages formosus UBN1, and 
Drosophila melanogaster Yemanuclein it is evident that the NHRD (residues 41-
77) and HRD (119-175) are very highly conserved, but there are additional 
regions of conservation, most notably the region spanning residues ~300-600 
(Figure 3.1). 
To compliment the multiple sequence alignment, we also performed secondary 
structure prediction for the human UBN1 protein sequence using the PSIPRED 
server (Buchan et al., 2013) (Figure 3.2). While the majority of human UBN1 has 
little predicted structure or low confidence prediction, UBN1 residues ~300-600 
are predicted to form helical secondary structure with high confidence of 
prediction. This, in combination with the metazoan sequence conservation,  
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Figure 3.1 – Alignment of UBN1 metazoan homologs and secondary structure 
prediction. (A) Alignment depicts sequence conservation among Homo sapiens UBN1, 
Mus musculus UBN1, Gallus gallus UBN1, Scleropages formosus UBN1, and Drosophila 
melanogaster Yemanuclein. The conserved UBN1 HRD (residues 120-175) (yellow line 
over sequence) and NHRD (residues 41-71) (green line over sequence) domains have 
been well characterized for their functions. UBN1 residues 176-700 are well conserved 
among metazoan species, although the biological function of this UBN1 region remains 
unclear. Note that Scleropages formosus represents UBN1 from a fish (Asian bonytongue), 
as there is not an annotated full-length sequence for UBN1 from Danio rerio. 
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Figure 3.2 – Secondary structure prediction for UBN1 residues 291-600. 
Secondary structure for UBN1(291-600) was predicted based on the amino 
acid sequence by the PSIPRED protein sequence analysis server. 
 
 
92
identifies this domain of UBN1 as a good target for functional characterization 
with biochemical and structural studies. As this domain has been 
uncharacterized for function in human UBN1, we preliminarily name this region 
the UBN1 middle domain. 
A construct encoding UBN1 middle domain residues 296-584, bearing an N-
terminal 6xHis that is removable with TEV protease, was generated and 
expressed in E. coli cells (Figure 3.3a). This UBN1(296-584) fragment was easily 
purified and stable in solution. Upon size-exclusion chromatography analysis 
using an s200 16/600 column (GE Healthcare), we observed this fragment of 
UBN1 forms two monodisperse populations that we call “peak 1” and “peak 2” 
(Figure 3.3b). Upon pooling and re-injecting the isolated populations back onto 
the size-exclusion column, it was observed that these populations are relatively 
stable and do not readily re-distribute back into the same two populations (Figure 
3.3b-c). To further analyze these stable UBN1(296-584) peaks, we then injected 
the isolated populations onto an analytical 10/300 s200 column (GE Healthcare) 
and compared the elution profiles to a set of molecular-weight standards (Biorad) 
(Figure 3.4a-b). Comparison with the standards indicates that peak 1 has an 
elution profile similar to that of the 158 kDa standard and peak 2 elutes just 
before the 44 kDa standard. To further verify our observations that these 
populations are non-exchanging, we performed a pull-down experiment where 
GST-UBN1(296-584) was incubated with untagged UBN1(296-584) from the  
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Figure 3.3 – Analysis of UBN1(296-584) with size-exclusion chromatography. (A) 
Domain architecture diagram depicting the characterized UBN1 NHRD, HRD and 
Middle domains. (B) Chromatograph of UBN1(296-584) resolved on a HiLoad s200 
16/600 size-exclusion column. Fractions from 65-75 mL were pooled and re-loaded 
onto the column for “Peak 1 Rerun”, while fractions from 76-89 mL were pooled and re-
loaded onto the column for “Peak 2 Rerun”. (C) SDS-PAGE gel analysis of 1 mL 
fractions spanning 65-89 mL for all three runs. 
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Figure 3.4 – UBN1(296-584) forms two non-exchanging monodisperse 
populations. (A) Chromatographs from UBN1(296-584) peak 1 and peak 2 
populations resolved on an analytical s200 10/300 size-exclusion column in 
comparison with molecular-weight standards. (B) SDS-PAGE gel analysis of 0.5 mL 
fractions spanning 10-16 mL for both runs. (C) GST pull-down confirming that both 
peak 1 and peak 2 are unable to form a complex with GST-UBN1(296-584), further 
indicating that these are stable and non-exchanging populations. 
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peak 1 or peak 2 populations (Figure 3.4c). We observed that both peak 1 and 
peak 2 are unable to form complexes with GST-UBN1(296-584), indicating that 
these populations do not exchange after they are initially formed.   
A theoretical monomer of UBN1(296-584) has a molecular weight of 33 kDa. To 
determine if these two UBN1 populations represent different oligomerization 
states we preformed a sedimentation equilibrium analytical-ultracentrifugation 
analysis of the two populations. Both peaks were monitored for the equilibrium 
distribution of three different protein concentrations (0.3, 0.5, 0.7 OD A280) at 
three centrifugation speeds (12000, 18000, 26000 RPM). The combined 
equilibrium data were globally fit with an ideal model to determine the average 
molecular weight of the protein in solution. Analysis of peak 1 determined an 
experimental molecular weight of 56.7 kDa (Figure 3.5), while analysis of peak 2 
determined an experimental molecular weight of 34.6 kDa (Figure 3.6). 
Comparison with the molecular weight of a theoretical UBN1(296-584) monomer 
(33 kDa) and dimer (66 kDa) indicates that peak 1 forms a majority dimer 
population while peak 2 forms a majority monomer population. For better 
visualization of peak 1 and peak 2 oligomerization states, representative curves 
from each population were plotted on a linear scale and compared with predicted 
curves for a theoretical UBN1(296-584) monomer, dimer, and trimer. In 
comparison with the predicted curves it appears that peak 2 aligns very well with  
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Figure 3.5 – Analytical ultracentrifugation of UBN1(296-584) peak 1 dimer.  
Sedimentation equilibrium of UBN1(296-584) peak 1 population, three different protein 
concentrations (0.3, 0.5, 0.7 OD A280) were analyzed for equilibrium distribution at three 
different speeds (12000, 18000, and 26000 RPM). These data were fit to the ideal fitting 
model using the program HeteroAnalysis. The ideal fit yielded an experimental 
molecular weight of 56741 Da, indicating this is a majority dimer population.  
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Figure 3.6 – Analytical ultracentrifugation of UBN1(296-584) peak 2 monomer. 
Sedimentation equilibrium of the UBN1(296-584) peak 2 population, three different 
protein concentrations (0.3, 0.5, 0.7 OD A280) were analyzed for equilibrium 
distribution at three different speeds (12000, 18000, and 26000 RPM). These data 
were fit to the ideal fitting model using the program HeteroAnalysis. The ideal fit 
yielded an experimental molecular-weight of 34642 Da, indicating this is a majority 
monomer population. 
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the predicted monomer, and peak 1 aligns best with the predicted dimer (Figure 
3.7). 
We then expressed and purified UBN1(341-584) in the same manner as 
UBN1(296-584) to monitor the effect of truncating the predicted N-terminal 
helices and loop (Figure 3.8a). UBN1(341-584) resolves into the same peak 1 
and peak 2 populations observed for UBN1(296-584) on an s200 16/600 column, 
the only major difference for this fragment was that we observed the formation of 
a specific degradation product that runs between the 18 kDa and 12 kDa 
molecular-weight standards on an SDS-PAGE gel (Figure 3.8b-c). We decided to 
preform LC-MS analysis on the degradation product and determined that the 
degradation product represented UBN1 residues 341-503.  
We then prepared UBN1(296-503) in the same manner as UBN1 (296-584) and 
UBN1(341-584) to identify the contribution of UBN1 residues 504-584 to the 
formation of the monomer and dimer populations (Figure 3.9a). When 
UBN1(296-503) was resolved on an s200 16/600 column, only one major peak 
with a small shoulder was observed (Figure 3.9b-c). We did not see the same 
distinctly separate populations observed for UBN1(296-584) and UBN1(341-
584), but we decided to treat the shoulder as a potentially separate population. 
We pooled and re-injected the shoulder and the main peak as peak 1 and peak 
2, respectively. We observed that both rerun of peak 1 and peak 2 resulted in 
formation of the same distribution as the original run, indicating that the peak  
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Figure 3.7 – Linear plot of UBN1(296-584) peak 1 / peak 2 sedimentation 
equilibrium data. Representative data for UBN1 peak 1 (bottom) and peak 2 (top) at 
0.5 OD and 18000 RPM were compared to predicted curves for a theoretical 
UBN1(296-584) monomer, dimer, and trimer. Theoretical curves were generated using 
the program HeteroAnalysis. To represent the data on a linear scale the curves were 
plotted using a logarithmic normalization.  
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Figure 3.8 – Analysis of UBN1(341-584) with size-exclusion chromatography. (A) 
Domain architecture diagram for UBN1 depicting middle domain fragments (B). 
Chromatograph of UBN1(341-584) resolved on a HiLoad s200 16/600 size-exclusion 
column. Fractions from 68-78 mL were pooled and re-loaded onto the column for 
“Peak 1 Rerun”, while fractions from 80-94 mL were pooled and re-loaded onto the 
column for “Peak 2 Rerun”. (C) SDS-PAGE gel analysis of every other 1 mL fraction 
spanning 68-97 mL for all three runs.  
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Figure 3.9 – Analysis of UBN1(296-503) with size-exclusion chromatography. (A) 
Domain architecture diagram for UBN1 depicting middle domain fragments. (B) 
Chromatograph of UBN1(296-503) resolved on a HiLoad s200 16/600 size-exclusion 
column. Fractions from 70-78 mL were pooled and re-loaded onto the column for “Peak 
1 Rerun”, while fractions from 80-90 mL were pooled and re-loaded onto the column for 
“Peak 2 Rerun”. (B) SDS-PAGE gel analysis of every other 1 mL fraction spanning 70-
99 mL for all three runs.  
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represents only the monomer population with a shoulder. This observation leads 
to the conclusion that residues 504-584 of UBN1 are required for dimer 
formation. We attempted to purify UBN1(504-584) as an MBP-UBN1(504-584) 
fusion, but this fragment formed very large soluble aggregates. We were unable 
to isolate soluble UBN1(504-584) with TEV protease cleavage and when MBP-
UBN1(504-584) was resolved on a superose 6 10/300 column the majority eluted 
in the void volume, indicating that this fragment of UBN1 is aggregated and not 
suitable for biophysical analysis in isolation (Figure 3.10). 
3.3 – The UBN1 middle domain specifically binds H3/H4 
 
Given our observation here that the UBN1 middle domain forms stable monomer 
and dimer populations, together with our previous finding that the UBN-HRD 
domain (residues 119-175) binds to H3.3/H4, we decided to test if the UBN1 
middle domain also binds to histones, potentially to contribute to (H3.3.H4)2 
deposition into chromatin. We prepared GST-UBN1(296-584) for a pull-down 
based histone-binding assay. GST-UBN1(296-584) was mixed with either 
H3.1/H4 or H3.3/H4 and binding was analyzed in buffer containing either 300 mM 
or 750 mM NaCl. We observed that UBN1(296-584) was able to bind H3.1/H4 
and H3.3/H4 with equal affinity, and the interaction was only evident in the 300 
mM NaCl buffer (Figure 3.11a), indicating that the interaction between H3/H4 and 
the UBN1 middle domain is electrostatic in nature and not specific for H3.3/H4. 
We then tested if the monomer or dimer population of UBN1(296-584) had any  
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Figure 3.10 – Analysis of MBP-UBN1 with size-exclusion chromatography 
MBP-UBN1(504-584) was resolved on a Superose 6 10/300 size-exclusion 
column. The majority of MBP-UBN1(504-584) eluted in the void volumn. 
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Figure 3.11 – UBN1(296-584) binds histones H3/H4 with no specificity for H3.3 
vs. H3.1. (A) GST pull-down conducted with GST-UBN1(296-584) and H3.3/H4 or 
H3.1/H4 at 300 mM and 700 mM NaCl. (B) Size-exclusion histone binding 
experiment where UBN1(296-584) peak 1 and peak 2 were mixed with excess 
H3.3/H4 and run on an analytical s200 10/300 column to analyze complex formation. 
(C) GST pull-down conducted using GST-UBN1(296-584) with H3.3/H4 or H2A/H2B 
alone or in combination to analyze binding specificity.  
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influence on this middle domain/histone interaction. We isolated UBN1(296-584) 
peak 1 or peak 2 and incubated the individual populations with excess H3.3/H4 
prior to resolving the mixtures over an s200 10/300 column, both the monomer 
and dimer populations were capable of forming a similar complex with H3.3/H4 
on the s200 column (Figure 3.11b). To determine if the middle domain interaction 
with H3/H4 is significant, or just a non-specific electrostatic interaction, we 
conducted a pull-down histone-histone binding assay to compare the middle 
domain interaction with H3/H4 and H2A/H2B. Both H3/H4 and H2A/H2B have a 
strong positive charge, but we hypothesized that UBN1 would likely show 
specificity towards H3/H4 if the interaction is biologically relevant. GST-UBN1 
(296-584) was incubated with H3.3/H4 or H2A/H2B individually as well as a 1:1 
pool of H3.3/H4 and H2A/H2B in competition. The pull-down show that GST-
UBN1(296-584) is able to bind H3.3/H4 but not H2A/H2B when the histones are 
assayed individually, and GST-UBN1(296-584) only binds H3.3/H4 from the 
competitive mixture (Figure 3.11c).  These studies demonstrate that the UBN1 
middle domain specifically binds H3/H4 but with no preference between H3.1 and 
H3.3. 
Following the discovery that the UBN1 middle domain interacts specifically with 
H3/H4 in an electrostatic dependent manner, we then assayed the significance of 
the flanking middle domain regions, 296-340 and 504-584, to the H3/H4 
interaction. GST-UBN1(296-503) and GST-UBN1 (341-503) were incubated with 
 
 
106
H3.3/H4 and subjected to pull-down. While GST-UBN1(296-503) was able to 
pull-down H3.3/H4, no interaction above background was observed for GST-
UBN1(341-503) (Figure 3.12a). Suggesting that UBN1 residues 504-584 are 
dispensable for H3/H4 binding, while the interaction is dependent on UBN1 
residues 296-340. There is some mild evolutionary conservation in the region of 
UBN1 residues 296-340, but nothing striking to target for individual point 
mutations (Figure 3.1). We employed a deletion strategy in this region instead 
and generated several N-terminal deletions to compare for H3/H4 binding; GST-
UBN1(296-503), GST-UBN1(316-503), GST-UBN1(331-503), and GST-
UBN1(341-503). Each UBN1 fragment was incubated with H3.3/H4 and 
subjected to GST pull-down (Figure 3.12b). We observed that GST-UBN1(296-
503) was able to form a stable complex with H3.3/H4, but with each successive 
N-terminal deletion we observed less H3.3/H4 being pulled-down, with GST-
UBN1 341-503 having no interaction above background. This result indicates that 
many amino acids within UBN1(296-340) contribute to H3/H4 binding.  
We then investigated if the middle domain binds to the folded histone core or the 
lysine-rich N-terminal tails. We previously characterized the UBN1-HRD/H3.3/H4 
interaction and showed that the HRD binds primarily to the folded histone core 
with a smaller contribution from the histone tails (Ricketts et al., 2015). GST-
UBN1(296-584) was incubated with either FL H3.3/H4 or N-terminally truncated 
H3.3(45-135)/H4(20-102) and subjected to pull-down. The results reveal that  
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Figure 3.12 – A region of UBN1 spanning residues 296-341 is involved in binding 
to the H3/H4 N-terminal tails. (A) GST pull-down conducted with H3.3/H4 and GST-
UBN1(296-503) or GST-UBN1(341-503). (B) GST pull-down conducted with H3.3/H4 
and various UBN1 fragments illustrating that residues 296-341 contribute to H3/H4 
binding. (C) GST pull-down conducted with GST-UBN1(296-503) and FL or ∆N 
H3.3/H4. 
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GST-UBN1(296-584) is able to pull-down significantly more FL H3.3/H4 in 
comparison with the N-terminally truncated complex (Figures 3.12c). This 
suggests that the UBN1 middle domain binds primarily to the N-terminal H3/H4 
tails.  
3.4 – UBN1 residues 176-295 non-specifically bind to DNA 
 
The UBN1 region of 176-295, located between the HRD and middle domain, has 
little predicted secondary structure and is extremely lysine rich. There is no 
significant conservation in this region with the UBN1 homolog Yemanuclein from 
D. melanogaster, but if Yemanuclein is excluded from the multiple sequence 
alignment, it becomes clear that the lysine rich loop is well conserved among 
vertebrate UBN1 homologs (Figure 3.13a-b). This observation in combination 
with the report that UBN1 has been shown to have stronger non-specific 
interaction with DNA in comparison with other members of the HIRA complex 
(Ray-Gallet et al., 2011) lead to the hypothesis that this region of UBN1 may be 
involved in non-specific binding to DNA. To address this hypothesis, we 
generated MBP-UBN1(122-584); harboring the HRD, lysing rich loop, and middle 
domain. Within MBP-UBN1(122-584) we made several deletions including the 
entire 175-296 loop as well as smaller stretches of conserved lysine residues. 
Additionally we generated MBP-UBN1(176-195) to address if the loop alone 
would be sufficient for DNA binding. We employed a fluorescence polarization 
based DNA binding assay to test interaction with DNA. A FAM labeled 46 bp  
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Figure 3.13 – UBN1 residues 176-295 bind to DNA with nanomolar affinity. 
(A) Alignment of UBN1 residues 176-295 with metazoan homologs. (B) 
Alignment of UBN1 176-295 with vertebrate homologs, lysine residues are 
clearly conserved among vertebrates. (C) Fluorescence polarization binding 
experiment conducted with MBP-UBN1 fragments and a double stranded LBS 
1/2 FP probe. Deletion analysis of UBN1 shows that conserved lysine residues 
harbored in the 176-295 region contribute to DNA binding affinity.  
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double-stranded LBS1/2 DNA, originally generated to study binding with the 
Kaposi’s sarcoma associated herpesvirus DNA-binding protein LANA (Domsic et 
al., 2013) was repurposed for our study as a non-specific DNA binding FP probe. 
We incubated the probe with increasing MBP-UBN1(122-584) to monitor the 
change in fluorescence polarization as the UBN1/DNA complex formed, and from 
the resulting FP curve we were able to determine the Kd of the UBN1/DNA 
interaction to be 113 nM (Figure 3.13c). Using the same FP assay we were able 
to show that MBP-UBN1(176-295) alone is able to bind DNA with a very 
comparable Kd of 90 nM, while MBP-UBN1(122-584, 176-295) did not have 
any detectable binding to DNA (Figure 3.13c). Additionally deletion of conserved 
lysine patches 182-195, 200-217, and 232-239 resulted in incomplete binding 
curves that could not be fit to determine Kd values, while deletion of 248-261 
resulted in reduced binding with a Kd of 245 nM (Figure 3.13c). These data 
combined indicate that the lysine rich UBN1 region of 176-295 is essential for 
non-specific DNA binding.  
To further confirm the veracity of our findings from the FP DNA binding assay, we 
analyzed MBP-UBN1(122-584) WT and 176-295 mutant for binding with 
LBS1/2 double stranded DNA without a FAM label on size-exclusion 
chromatography. MBP-UBN1(122-584) WT was incubated with 2-fold molar 
excess LBS1/2 double stranded DNA and resolved the complex on an s200 
10/300 column superose 6 10/300 column. In this experiment, we observed a 
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significant shift in the elution volume of the MBP-UBN1(122-584) upon addition of 
DNA, indicating a higher molecular weight complex is formed with DNA (Figure 
6d). While MBP-UBN1(122-584, 176-295) had no observable complex 
formation with the addition of DNA (Figure 3.14).  
We then generated a new double stranded DNA fragment to compare with the 
LBS1/2 one we have been using to confirm that the DNA interaction is not 
dependent on local sequence. The double stranded DNA was 40 base pairs long, 
composed of 10 repeats of “ATGC”, which we named 10xATGC. Excess 
10xATGC was incubated with MBP-UBN1(176-295) and the mixture was 
resolved on both the s200 and superose 6 10/300 size-exclusion column. In the 
same manner as LBS1/2 with MBP-UBN1(122-584), the 10xATGC formed a 
complex with MBP-UBN1(176-295), resulting in shift for the larger molecular 
weight species on the size-exclusion column in comparison with MBP-
UBN1(176-295) resolved alone (Figure 3.15). These data indicate that UBN1 is 
able to bind both DNA sequences in a similar manner. 
To quantitatively compare the 10xATGC and LBS1/2 interactions as well as 
probe the DNA specificity of the interaction, a competition FP experiment was 
preformed to compare the ability of 10xATGC DNA, Heparin, and tRNA to 
compete UBN1 from the FAM-LBS1/2 DNA. Heparin and tRNA represent non-
DNA molecules with strong negative charge. 10xATGC DNA was able to  
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Figure 3.14 – Size-exclusion analysis of UBN1 / DNA complex formation. 
(A) MBP-UBN1(122-584) resolved on an s200 10/300 alone (top) or with 2-
fold excess LBS1/2 double stranded DNA (bottom). (B) MBP-UBN1(122-584) 
resolved on a superpose 6 10/300 alone (top) or with 2-fold excess LBS1/2 
double stranded DNA (bottom). (C) MBP-UBN1(122-584, ∆176-295) resolved 
on an s200 10/300 alone (top) or with 2-fold excess LBS1/2 double stranded 
DNA (bottom). 
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Figure 3.15 – Size-exclusion analysis of UBN1(176-295) / DNA complex formation. 
(A) MBP-UBN1(176-295) resolved on an s200 10/300 alone (top) or with 2-fold excess 
10xATGC double stranded DNA (bottom). (B) MBP-UBN1(176-295) resolved on a 
superpose 6 10/300 alone (top) or with 2-fold excess 10xATGC double stranded DNA 
(bottom). 
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compete UBN1(122-584) away from FAM-LBS1/2 with an IC50 or 182 nM, while 
heparin had an IC50 of 80 nM and tRNA had an IC50 of 430 nM (Figure 3.16). 
While there is some variability among the IC50 value for the three competitors, all 
interactions are on the same order of magnitude, indicating that UBN1 residues 
176-295 have a propensity to non-specifically bind negatively charged species. 
Although the interaction is based on non-specific charge, these results, together 
with the known biological activity of UBN1 to participate in histone deposition into 
chromatin is most consistent with a biologically significant role of UBN1 in DNA 
binding.  
3.5 – The UBN1 HRD and middle domain bind H3/H4 in a mutually exclusive 
manner 
 
As both the UBN1 HRD and middle domain have histone bindings activity, we 
investigated if they represent partial interactions of a larger UBN1/H3.3/H4 
complex. First we mixed UBN1(296-584), UBN1(92-175), and H3.3/H4 in a 2:2:1 
ratio and resolved the mixture over an s200 10/300 size-exclusion column. We 
observed that UBN1(92-175) appears to form complex with H3.3/H4 but UBN1 
(296-584) does not appear incorporated in the complex (Figure 3.17a top). To 
further verify this result we ran the same column with just the 2:1 ratio of UBN1 
(92-175) and H3.3/H4 and observed that the UBN1(92-175)/H3.3/H4 complex 
elutes in the same fractions, showing that there is no shift upon addition of 
UBN1(296-584) (Figure 3.17a bottom). Following this result, we analyzed if either  
 
 
115
 
 
 
 
 
 
 
 
 
 
 
Figure 3.16 – UBN1 binds DNA though a non-specific electrostatic 
mechanism. A fluorescence polarization competition experiment was conducted 
by pre-forming a complex of UBN1 with FAM tagged LBS1/2 DNA. This complex 
was then titrated with heparin, tRNA, or double stranded 10xATGC DNA to 
determine the IC50 for the competitors.  
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Figure 3.17 – The UBN1 HRD and middle domain bind histones in a mutually 
exclusive manner. (A) Size-exclusion experiment performed by adding 2-fold 
excess UBN1(296-584) and UBN1(92-175) to H3.3/H4 and resolving the mixture on 
an s200 10/300 column (top), control was run by adding 2-fold 92-175 to H3.3/H4 
without UBN1(296-584) (bottom). (B) GST pull-down conducted by mixing GST-
UBN1(92-175), H3.3/H4, and either UBN1(296-584) peak 1 or peak 2. 
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the UBN1(296-584) monomer or dimer populations could alter the mutually 
exclusive nature of the UBN1 HRD and middle domain histone interactions. A 
pull-down histone-binding assay was preformed though incubating either 
UBN1(296-584) monomer or dimer population with GST-UBN1(92-175) and 
H3.3/H4 prior to GST pull-down. Neither the UBN1(296-584) monomer or dimer 
were able to be incorporated into the GST-UBN1(92-175)/H3.3/H4 complex, and 
the interaction level for GST-UBN1(92-175) with H3.3/H4 was not altered by the 
addition of a UBN1(296-584) monomer or dimer competitor (Figure 3.17b). 
These observations combined lead to the conclusion that the UBN1-HRD and 
middle domain interact with H3.3/H4 in a mutually exclusive manner. Although 
this is somewhat confounding, the observations may be explained by a hand-off 
mechanism. While we observe preferential interaction of H3.3/H4 with the HRD 
over the middle domain, there may be some sort of biological switch, such as a 
post-translational modification or allosteric process, that allows for handoff from 
one domain to the other, although further investigation is necessary to confirm 
this hypothesis. 
3.6 – UBN1 binds free H3/H4 but does not bind nucleosomes 
 
Following our observations that UBN1 has an additional histone tail binding 
region as well as a DNA binding region, we investigated if these newly 
characterized domains in UBN1 could be involved in nucleosome binding. 
Nucleosomes were prepared with histones H3.1, H4, H2A, and H2B and a 147 
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bp double stranded DNA fragment bearing the 601 nucleosome positioning 
(Luger et al., 1999). Although UBN1-HRD binding is selective for H3.3/H4 
(Ricketts et al., 2015), the UBN1 middle domain binds H3.1/H4 and H3.3/H4 with 
similar affinity and the H3.3-specific contact surface of the UBN1-HRD is not 
accessible in the nucleosome core particle (Figure 3.12c). We compared binding 
of nucleosomes versus H3.3/H4 alone with several different UBN1 fragments in a 
pull-down based binding assay. MBP-UBN1(122-584, WT), MBP-UBN1(122-584, 
176-295), GST-UBN1(296-584), and GST-UBN1(122-175) were incubated with 
nucleosomes or H3.3/H4 and subjected to pull-down. We observed that while all 
four UBN1 fragments were capable of binding free H3.3/H4, none showed any 
detectable binding with nucleosomes (Figure 3.18). We also preformed the 
nucleosome pull-down for MBP-UBN1(122-584, WT) and MBP-UBN1(122-584, 
176-295) at 150 mM NaCl in addition to 300 mM, we still observed no 
nucleosome binding at the lower salt concentration (Figure 3.18).  Based on 
these results, we conclude that UBN1 does not participate in nucleosome 
binding. 
3.7 – Discussion 
 
UBN1 is an essential member of the HIRA complex, but only two very small 
domains have been studied in any depth. In our attempt to characterize regions 
of UBN1 outside of the well studied HRD and NHRD domains, we have identified 
the middle domain as a structured region of UBN1 that has dimerization and  
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Figure 3.18 – UBN1 does not bind Nucleosomes. Pull-down experiment 
comparing ability of MBP-UBN1(122-584, WT), MBP-UBN1(122-584, ∆176-
295), GST-UBN1(296-584), and GST-UBN1(122-175) to bind free H3.3/H4 or 
nucleosomes. As UBN1 residues 176-295 have been shown to contribute to 
DNA binding, the pull-down with MBP-UBN1(122-584, WT) and MBP-
UBN1(122-584, ∆176-295) was attempted at 150 mM NaCl as well as 300 mM 
NaCl.  
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histone H3/H4 binding activity. Additionally, we also identified that the loop 
separating the HRD and middle domain harbors many conserved lysine residues 
that harbor non-specific DNA binding activity. Finally, we have shown that 
although UBN1 is capable of binding H3/H4 and DNA in isolation, it does not 
associate with assembled nucleosomes. Several studies have identified dimer-
formation in other histone chaperones that bind to an (H3.3/H4)2 tetramer for 
nucleosome deposition (Fazly et al., 2012; Huang et al., 2015; Richet et al., 
2015; Su et al., 2012; Winkler et al., 2012; Zasadzinska et al., 2013), and it was 
previously demonstrated that the majority of H3.3/H4 is deposited into 
nucleosomes in the tetramer form (Xu et al., 2010). Furthermore, human UBN1 
has been previously shown to exhibit DNA binding activity (Ray-Gallet et al., 
2011), as have several other histone chaperones such as FACT (Safina et al., 
2017) and CAF-1 (Sauer et al., 2017; Zhang et al., 2016). From these 
observations in combination with ours, we propose a model for HIRA complex 
function in which UBN1 binds and stabilizes an (H3.3/H4)2 tetramer in concert 
with DNA binding, prior to H3.3/H4 deposition and final nucleosome assembly 
with the aid of additional histone chaperones and cellular factors (Figure 3.19).  
Experiments with the full-length HIRA complex and different HIRA sub-
complexes are needed to rigorously confirm our model, as we have only 
observed a lack of nucleosome binding for UBN1 in isolation. It has recently been 
reported that the WD40 domain of HIRA is essential for nucleosome assembly  
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Figure 3.19 – Proposed model for H3.3/H4 deposition by the HIRA complex 
Proposed model for H3.3/H4 deposition coordinated by the HIRA complex based on our 
observation. The three-step model first shows an H3.3/H4 dimer bound by ASF1 and the 
UBN1-HRD. Next, UBN1 binds DNA and middle domain forms a dimer and associates 
with H3.3/H4 to displace ASF1a and the UBN1-HRD to allow for (H3.3/H4)2 tetramer 
formation. Finally the HIRA complex disassociates from the (H3.3/H4)2 tetramer and 
DNA to allow additional chaperones to deposit H2A/H2B and coordinate final 
nucleosome formation.  
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(Zhu et al., 2017), although this observation could be due to the function of HIRA 
as a molecular scaffold for the HIRA complex, as the UBN1-NHRD binds to the 
HIRA-WD40 domain (Tang et al., 2012). Additionally, our observation of mutually 
exclusive H3.3/H4 binding by the UBN1-HRD and middle domain is somewhat 
confounding, further investigation will be required to determine if there is a 
potential hand-off or other allosteric mechanism that could be driven by a yet to 
be determined factor. Of particular interest to our studies is that the CAF-1 
complex has recently been reported to form an H3/H4 tetramer only upon binding 
to an H3/H4 dimer together with DNA, which allows for the formation of a CAF-1 
dimer to drive (H3/H4)2 tetramer formation prior to deposition (Mattiroli et al., 
2017). Perhaps UBN1 could operate through a similarly triggered mechanism. 
While there is still much that remains unknown about how the HIRA complex and 
other histone chaperones mediate histone deposition, our data suggests that 
UBN1 may function similarly to other H3/H4 histone chaperones though a 
mechanism that employs both dimerization and DNA binding activities to 
efficiently deposit (H3.3/H4)2 onto DNA for nucleosome formation. 
3.8 – Materials and Methods 
 
Multiple sequence alignments 
Alignments for Figures 3.1 and 3.13 were generated using Clustal Omega 
(Sievers et al., 2011), and formatted for better visualization using ESPript version 
3.0 (Gouet et al., 2003).  
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Protein secondary structure prediction 
Predicted secondary structure of UBN1 depicted in Figure 1b was generated 
using the PSIPRED secondary structure prediction server (Buchan et al., 2013).  
Generation of expression plasmids 
The plasmids encoding His-UBN1(296-584), His-UBN1(341-584), and His-
UBN1(296-503) were generated by PCR amplification from a FL UBN1 construct 
(Banumathy et al., 2009) and ligation into the BamHI/XhoI sites of a custom 
engineered pCDFduet-1 (Novagen) Escherichia coli expression vector carrying a 
N-terminal 6xHis tag that is removable by TEV protease cleavage. The plasmids 
encoding GST-UBN1(296-584), GST-UBN1(296-503), GST-UBN1(316-503), 
GST-UBN1(330-503), GST-UBN1(341-503), GST-UBN1( 92-175), and GST-
UBN1(122-175) were generated by PCR amplification and ligation into the 
BamHI/XhoI sites of a custom engineered pCDFduet-1 (Novagen) Escherichia 
coli expression vector carrying a N-terminal GST tag that is removable by TEV 
protease cleavage. The plasmid encoding His-MBP-UBN1(122-584) was 
generated by PCR amplification and ligation into the BamHI/XhoI sites of a 
pDB.His.MBP Escherichia coli expression vector carrying a N-terminal His-MBP 
tag that is removable by TEV protease cleavage (Seiler et al., 2014). The 
plasmids encoding His-MBP-UBN1(122-584, 176-295), His-MBP-UBN1(122-
584, 182-195), His-MBP-UBN1(122-584, 200-217), His-MBP-UBN1(122-584, 
232-239), and His-MBP-UBN1(122-584, )were generated by 
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site-directed mutagenesis(Weiner and Costa, 1994). The plasmids encoding FL 
H3.1, H3.3, and H4 were generated as described previously (Ricketts et al., 
2015). The plasmid encoding H2B was a gift from Don Cleveland at UCSD. The 
plasmids encoding H3.3(45-135) and H4(20-102) were generated by PCR 
amplification of the H3.3 and H4 sequences and ligation into the BamHI/XhoI 
sites of custom engineered pETduet-1 (Novagen) Escherichia coli expression 
vector carrying a N-terminal His tag that is removable by TEV protease cleavage. 
Protein expression and purification 
H2A, H2B, H3, and H4 individual histone proteins were expressed to the 
inclusion bodies in BL21-Gold(DE3) cells (Agilent). The individual histone 
proteins were purified and refolded to form H3/H4 and H2A/H2B as previously 
described (Luger et al., 1999; Ricketts et al., 2015). These proteins were 
additionally used to form nucleosomes with the addition of 601 nucleosome 
positioning sequence double stranded DNA according to a previously reported 
protocol (Luger et al., 1999). His-UBN1(296-584), His-UBN1(341-584), and His-
UBN1(296-503) were generated in BL21-Gold(DE3) cells (Agilent) induced with 
0.8 mM IPTG and expressed overnight at 18°C. Cells were re-suspended in 
buffer containing 20 mM Tris pH 8.0, 500 mM NaCl, 5 mM BME, and 10 mM 
imidazole and lysed with sonication. Lysate was clarified with centrifugation and 
the supernatant was subjected to nickel affinity chromatography to isolate the His 
tagged protein. Proteins were eluted with 200 mM Imidazole and dialyzed 
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overnight with the addition of TEV protease to remove the His tag, dialysis buffer 
contains 20 mM Tris pH 7.5, 50 mM NaCl, and 5 mM BME. Proteins were then 
subjected to ion exchange chromatography using a HiTrap SP column (GE 
Healthcare). Following ion exchange, proteins were concentrated using a spin 
concentrator (Millipore) and loaded either onto a Superdex 200 10/300 or 16/600 
column (GE Healthcare) in buffer with 20 mM Tris pH 7.5, 300 mM NaCl, and 1 
mM TCEP for further purification and analysis by gel filtration. GST-UBN1(296-
584), GST-UBN1(296-503), GST-UBN1(316-503), GST-UBN1(330-503), GST-
UBN1(341-503), GST-UBN1( 92-175), and GST-UBN1(122-175) were generated 
in BL21-Gold(DE3) cells (Agilent) induced with 0.8 mM IPTG and expressed 
overnight at 18°C. Cells were re-suspended in 1XPBS supplemented with 5 mM 
BME and lysed by sonication. Lysate was clarified by centrifugation and 
supernatant was subjected to GST affinity chromatography. Protein was eluted 
with 20 mM reduced glutathione and dialyzed into a buffer containing 20 mM Tris 
pH 7.5, 300 mM NaCl and 5 mM BME for storage. UBN1 92-175 was generated 
by adding TEV protease to GST-UBN1 92-175 bound to GST affinity resin 
followed by incubation at 4°C overnight. Cleaved protein was eluted with a buffer 
containing 20 mM Tris pH 7.5, 300 mM NaCl, and 5 mM BME. Eluted protein was 
concentrated using a spin concentrator (Millipore) and loaded onto a Superdex 
75 10/300 (GE Healthcare) for further purification by gel filtration in buffer with 20 
mM Tris pH 7.5, 300 mM NaCl, and 1 mM TCEP. His-MBP-UBN1(122-584, 
176-295), His-MBP-UBN1(122-584, 182-195), His-MBP-UBN1(122-584, 
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200-217), His-MBP-UBN1(122-584, 232-239), and His-MBP-UBN1(122-584, 
)were expressed and purified in the same method as His-
UBN1(296-584), His-UBN1 (341-584), and His-UBN1(296-503) with omission of 
the TEV cleavage step.  
Size-exclusion analysis of UBN1 peak 1 and peak 2 distribution 
UBN1(296-584) was purified though the ion exchange step, protein eluted from 
the ion exchange column was pooled and loaded onto a Superdex 200 16/600 
column (GE Healthcare) in buffer containing 20 mM Tris pH 7.5, 300 mM NaCl, 
and 1 mM TCEP. Protein eluting in the range of 65-75 mL was pooled as peak 1 
and protein eluting in the range of 76-89 mL was pooled as peak 2.  Both peak 1 
and peak 1 were re-loaded back onto the column for further analysis of 
distribution. UBN1(341-584) was analyzed in the same method as UBN1(296-
584) with the exception that peak 1 was defined as 68-78 mL and peak 2 was 
defined as 80-94 mL. UBN1(296-503) was analyzed in the same method as 
UBN1(296-584) with the exception that peak 1 was defined as 70-78 mL and 
peak 2 was defined as 80-90 mL. Analysis of UBN1(296-584) peak 1 and peak 2 
on the analytical Superdex 200 10/300 column was conducted by loading protein 
isolated from the first run on the Superdex 200 16/600 onto the analytical column 
for comparison with molecular-weight standards (Biorad).  
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Analytical ultracentrifugation – sedimentation equilibrium 
UBN1(296-584) peak 1 was prepared for sedimentation equilibrium analysis by 
conducting an initial gel filtration run on a Superdex 200 16/600.  Protein eluting 
in the region of 65-75 mL was pooled and re-loaded onto the Superdex 200 
16/600, the protein eluting in the same region for the second run was then pooled 
and analyzed for concentration. Samples were prepared at 0.3, 0.5, and 0.7 OD 
280 nm, loaded into a 6-channel ultracentrifugation cell with buffer blanks, and 
analyzed for equilibrium distribution analysis at 12000, 18000, and 26000 RPM 
using an Optima XL-I analytical ultracentrifuge (Beckman). Equilibrium 
distribution data were fit with the program HeteroAnalysis using the ideal fitting 
model (Cole, 2004). UBN1(296-584) peak 2 was prepared for sedimentation 
equilibrium analysis by conducting an initial gel filtration run on a Superdex 200 
16/600.  Protein eluting in the region of 76-89 mL was pooled and re-loaded onto 
the Superdex 200 16/600. The protein eluting in the same region for the second 
run was then pooled and analyzed for concentration. Protein was analyzed for 
equilibrium distribution similarly to peak 1. 
LC-MS analysis of protein samples 
LC-MS digestion and peptide analysis was preformed by the proteomics and 
metabolomics facility at The Wistar Institute in Philadelphia, Pennsylvania. We 
provided the facility with an SDS-PAGE gel stained with coomassie brilliant blue 
and indicated the protein bands for analysis.  
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GST/MBP pull-down binding assay 
Pull-down experiments were conducted by incubating 2 µM tagged bait protein 
with 4 µM untagged prey protein for 30 minutes at 4°C. Proteins were then 
subjected to pull-down by incubation with glutathione agarose (Fisher Scientific) 
or amalyose (NEB) resin for 30 minutes. Bound resin was washed with 120 
column volumes of buffer before elution of bound proteins by boiling resin in SDS 
loading buffer. Pull-downs were analyzed by visualization using SDS-PAGE 
stained with coomassie brilliant blue G-250. All pull-downs were conducted in 
buffer with 20 mM Tris pH 7.5, 300 mM NaCl, and 1 mM TCEP with the 
exception of Figure 3.11a which was conducted in both this buffer and one with 
750 mM NaCl, and Figure 3.18 which was conducted in both this buffer and one 
with 150 mM NaCl. Pull-down conducted in Figure 7b was conducted by mixing 2 
µM GST-UBN1(92-175), 2 µM H3.3/H4 and 4 µM UBN1(296-584) peak 1 or peak 
2.  
Formation of protein/protein complexes using size-exclusion chromatography 
To form complexes with UBN1(296-584) peak 1 or peak 2 and H3.3/H4 for 
Figure 3.11c, 200 µM UBN1 (296-584) was incubated with 400 µM H3.3/H4 and 
resolved on a Superdex 200 10/300 column (GE Healthcare) in a buffer with 20 
mM Tris pH 7.5, 300 mM NaCl, and 1 mM TCEP. H3.3/H4 was run alone at a 
concentration of 100 µM. For analysis of UBN1 92-175 and UBN1 296-584 
H3.3/H4 binding cooperation for Figure 3.17; 200 µM UBN1 296-584, 200 µM 
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UBN1 92-175 and 100 µM H3.3/H4 were incubated in a buffer containing 20 mM 
Tris pH7.5, 300 mM NaCl, and 1 mM TCEP and resolved on a Superdex 200 
10/300 column (GE Healthcare). Analysis of UBN1 92-175 and H3.3/H4 alone 
was conducted by incubating 200 µM UBN1 92-175 with 100 µM H3.3/H4 and 
resolving the mixture on the column in the same 20 mM Tris pH 7.5, 300 mM 
NaCl, 1 mM TCEP buffer.  
DNA probes 
The FAM labeled LBS1/2 (LANA binding sites 1 and 2) double stranded DNA 
used for the fluorescence polarization DNA binding assay was assembled from 
synthesized DNA fragments (IDT). This FAM labeled probe contains a DNA 
sequence recognized by the KSHV protein LANA and was originally used to 
study this interaction(Domsic et al., 2013), it was repurposed for our study as 
UBN1 has non-specific DNA binding activity. Unlabeled LBS1/2 and 10XATGC 
double stranded DNA was assembled from synthesized sense and anti-sense 
fragments. Sense fragment sequences:  
LBS1/2: 
AGCGGCCCCATGCCCGGGCGGGAGGCGCCGCAGGCCCCGGCGGCGT   
10XATGC: 
ATGCATGCATGCATGCATGCATGCATGCATGCATGCATGCATGCATGC 
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Sense and anti-sense fragments were dissolved in a buffer with 10 mM Tris pH 
7.5, 10 mM NaCl, and 1 mM EDTA, mixed in a 1:1 ratio and boiled followed by 
slow cooling to room temperature to anneal and form double stranded DNA. 
Fluorescence polarization DNA-binding assay 
To quantitatively analyze the UBN1/DNA interaction, a fluorescence polarization 
based binding assay was performed. Protein and DNA used for this assay were 
prepared in buffer containing 20 mM Tris pH 7.5, 150 mM NaCl, 1 mM TCEP, 
and 2 mg/mL BSA. The change in fluorescence polarization was monitored as 
increasing concentration of UBN1 protein was titrated into FAM-LBS1/2 DNA (10 
nM) to determine the Kd of the UBN1/DNA interaction. All data were collected 
using a Perkin Elmer EnVision Xcite Multilabel plate reader, and curves were fit 
using a one site – total binding model with GraphPad Prism (version 5.0a). A 
competition-binding assay was also performed to determine the IC50 for the 
interaction between UBN1 and: Heperin (Fisher), tRNA, and 10XATGC DNA. To 
monitor the ability of each competitor to compete UBN1 from LBS1/2 DNA, 
increasing concentration of competitor was titrated into solution containing 10 nM 
FAM-LBS1/2 and 300 nM MBP-UBN1(122-584). The tRNA used for this study 
was a pooled tRNA purified from yeast (Invitrogen). 
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CHAPTER 4:  Molecular characterization of HIRA oligomer formation and 
interaction with CABIN1 
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4.1 – Overview 
 
The human HIRA histone chaperone complex carries out deposition of H3.3/H4 
into chromatin in a replication independent manner(Tagami et al., 2004); H3.3/H4 
deposition by the HIRA complex is necessary for proper regulation of gene 
expression (Banaszynski et al., 2013; Goldberg et al., 2010; Jullien et al., 2012), 
as well as DNA and chromatin repair and maintenance (Adam et al., 2013; Ray-
Gallet et al., 2011; Schneiderman et al., 2012; Zhang et al., 2007). The complex 
is composed of the proteins HIRA, UBN1, and CABIN1, which are supplied with 
H3.3/H4 by the transient subunit ASF1a. The assembly and function of the HIRA 
complex has been relatively well studied; the individual protein/protein contacts 
responsible for complex formation for HIRA/UBN1(Tang et al., 2012), 
HIRA/ASF1a(Tang et al., 2006; Zhang et al., 2005), and UBN1/H3.3/H4(Ricketts 
et al., 2015) have been the focus of in depth biochemical and structural studies. 
However, the molecular contacts responsible for formation of the HIRA/CABIN1 
complex remain relatively unclear. It has been reported that CABIN1 residues 1-
941 are sufficient and necessary for complex formation with HIRA, and that this 
interaction is also dependent on HIRA residues 520-1017. It has been reported 
that CABIN1 is dispensable for H3.3/H4 deposition by the HIRA complex, while 
HIRA and UBN1 are essential for H3.3/H4 function(Ray-Gallet et al., 2011). 
Despite not being required for H3.3/H4 deposition, CABIN1 is an important 
member of the HIRA complex as knockdown of CABIN1 has been reported to 
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decrease cellular expression of HIRA, and knockdown/microarray studies have 
shown HIRA and CABIN1 regulate expression for many of the same genes(Rai 
et al., 2011). CABIN1 has been reported to interact with the transcription factors 
Mef2 and p53 (Choi et al., 2013; Esau et al., 2001; Jang et al., 2009; Youn and 
Liu, 2000), and a crystal structure of a CABIN1 peptide bound to Mef2 has been 
reported(Han et al., 2003). The existing evidence leads to the hypothesis that 
CABIN1 could play a role in the structural stability of the HIRA complex and may 
bind with some transcription factors to recruit the HIRA complex to specific areas 
of chromatin. To address this hypothesis, additional investigation into the 
protein/protein contacts responsible for HIRA/CABIN1 complex formation are 
necessary in order to design rational experiments to probe the biological 
significance of the HIRA/CABIN1 interaction.  
Based on the gap in knowledge outlined above, we decided to carry out 
experiments to probe the region of HIRA that interacts with CABIN1 as well as 
the HIRA/CABIN1 interaction.  We anticipated that these studies would provide 
insights into the roles played HIRA and CABIN1 H3.3/H4 deposition by the HIRA 
complex. Our studies were facilitated by unpublished cellular data from a 
collaborator demonstrating that HIRA residues 600-1017 are responsible for 
HIRA oligomer formation as well as CABIN1 binding. Specifically, our 
collaborators demonstrated that deletion within this HIRA domain abrogated co-
IP of differentially tagged HIRA as well as CABIN1 (data not shown), suggesting 
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that oligomer formation and CABIN1 binding by this HIRA domain may be 
functionally linked. Here we present biochemical data demonstrating that 
HIRA(661-1017) exists a stable trimer in solution and is able to form a complex 
with CABIN1. Sedimentation equilibrium experiments show that the 
HIRA/CABIN1 complex has a stoichiometry of HIRA(3)/CABIN1(2). We 
demonstrate that HIRA trimer formation is dependent on the presence of two 
linked domains within this HIRA region; HIRA(661-872) likely forms a strand 
domain and HIRA(905-1017) a helical domain, the two are linked by a loop 
spanning residues 873-904. We show that replacing the HIRA 873-904 loop with 
a glycine/serine linker still allows for trimer formation while abrogating CABIN1 
binding. Further we show that a HIRA F870A_R871A_L874A triple mutant 
decreases the HIRA/CABIN1 interaction. Together these data suggest that 
HIRA/CABIN1 complex formation is dependent on HIRA trimer formation, while 
specific contacts in the region of the HIRA(873-904) loop are additionally 
necessary for CABIN1 interaction. 
4.2 – The HIRA C-terminal domain forms a trimer and interacts with CABIN1 
 
We first set out to make a C-terminal fragment of HIRA that could be stably 
expressed and purified from E. coli. While the N-terminal region of HIRA has 
been well characterized as a predicted WD40 repeat domain, the C-terminal 
region of HIRA has been relatively understudied. We used the PSIPRED server 
(Buchan et al., 2013) to predict the secondary structure for HIRA residues 651-
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1017 (Figure 4.1 top), which shows that this HIRA region is largely structured and 
organized into a strand region (~residues 670-860) and helical region (~residues 
885-1017). We have assigned these previously uncharacterized domains on a 
new HIRA domain architecture schematic (Figure 4.1 bottom). We decided to 
generate a plasmid for expression of HIRA(661-1017), and were able to 
successfully purify HIRA(661-1017) from E. coli. We showed that this HIRA 
fragment forms a stable monodisperse population eluting between the 158 kD 
and 44 kD standards on a Superdex 200 10/300 GL column (Figure 4.2a). This 
domain of HIRA has previously been reported to interact with H3.3/H4, with 
increased interaction for H3.3/H4 bearing phosphorylation on H4 S47(Kang et al., 
2011). To test this interaction we incubated HIRA(661-1017) with 2-fold molar 
excess H3.3/H4 and resolved the mixture on a Superdex 200 10/300 GL column. 
We observed no complex formation (Figure 4.2b), although this experiment still 
needs to be repeated with H3.3/H4 harboring the S47 phosphorylation on H4. 
To study complex formation with CABIN1 FL we incubated 5-fold molar excess 
HIRA(661-1017) with CABIN1 FL purified from Sf9 cells and resolved the mixture 
on a Superdex 200 10/300 GL column in comparison with HIRA(661-1017) and 
CABIN1 FL run alone on the same column (Figure 4.3a-b). We observed an 
increased molecular weight shift and co-migration of the HIRA and CABIN1 
bands on an SDS-PAGE gel, indicating that HIRA(661-1017) forms a stable 
complex with CABIN1 FL in this assay.  
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Figure 4.1 – Secondary structure prediction and domain architecture for 
HIRA. (Top) Secondary structure prediction for HIRA(651-1017) depicting the 
predicted strand domain spanning residues 670-860 and the predicted helical 
domain spanning residues 885-1017. (Bottom) Domain architecture diagram for 
full-length human HIRA.  
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Figure 4.2 – Size-exclusion analysis of HIRA(661-1017) alone and with 
H3.3/H4. (A) HIRA(661-1017) elutes from an s200 10/300 GL size exclusion 
column in a monodisperse peak which sits between the 158 and 44 kD standard 
peaks. (B) HIRA(661-1017) was mixed with 2-fold excess H3.3/H4 and resolved 
on the s200 10/300 GL column, it appears as if no complex is formed between 
the proteins.  
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Figure 4.3 – Size-exclusion analysis of HIRA(661-1017) and CABIN1. (A) 
Excess HIRA(661-1017) was mixed with CABIN1 FL and resolved on a Superose 
6 10/300 GL column, a HIRA/CABIN1 complex appears be co-migrating on the 
column. (B) CABIN1 FL and HIRA(661-1017) were resolved individually on the 
same Superose 6 column. Dashed lines represent where CABIN1 FL elutes 
individually.  
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We then sought to better understand the biophysical nature of the HIRA/CABIN1 
complex. HIRA(661-1017), CABIN1 FL, and HIRA/CABIN1 complex that were 
resolved on size-exclusion chromatography.  To do this, each of the resolved 
size-exclusion peaks were subjected to analytical ultracentrifugation to determine 
the molecular assembly of the proteins alone as well as the complex. 
Sedimentation equilibrium analysis of HIRA(661-1017) alone indicates that the 
species has a solution molecular weight of 117416 Da.  A comparison with the 
theoretical molecular weight of a HIRA(661-1017) monomer indicates that this 
HIRA fragment exists as a stable trimer in solution (Figure 4.4). While analysis of 
CABIN1 alone indicates a molecular weight of 244736 Da, which in comparison 
with a theoretical molecular weight of 246352 Da for a monomer suggests that 
CABIN1 alone exists as a monomer in solution (Figure 4.5). Interestingly when 
we analyzed the equilibrium distribution of the HIRA/CABIN1 complex it revealed 
an experimental molecular weight of 605989 Da (Figure 4.6). This indicates that 
the complex is likely a HIRA(3)/CABIN1(2) complex, which would have a 
theoretical molecular weight of 610982 Da. For clear visualization of these data 
we have plotted representative curves for HIRA(661-1017), CABIN1 FL, and the 
HIRA/CABIN1 complex on a linear scale in comparison with predicted data for 
various molecular assemblies (Figure 4.7). 
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Figure 4.4 – Analytical ultracentrifugation of HIRA(661-1017). (A) 
Sedimentation equilibrium was performed with HIRA(661-1017) alone, three 
different protein concentrations (0.3, 0.5, 0.7 OD A280) were analyzed for 
equilibrium distribution at three different speeds (6000, 9000, and 12000 RPM). 
These data were fit to the ideal fitting model using the program HeteroAnalysis. 
The ideal fit yielded an experimental molecular weight of 117416 Da, indicating 
this is population may represent a HIRA trimer. 
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Figure 4.5 – Analytical ultracentrifugation of CABIN1. (A) Sedimentation 
equilibrium was performed with CABIN1 alone, three different protein 
concentrations (0.2, 0.4, 0.6 OD A280) were analyzed for equilibrium distribution 
at three different speeds (6000, 9000, and 12000 RPM). These data were fit to 
the ideal fitting model using the program HeteroAnalysis. The ideal fit yielded an 
experimental molecular weight of 244736 Da, indicating this is population may 
represent a CABIN1 monomer. 
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Figure 4.6 – Analytical ultracentrifugation of the HIRA/CABIN1 complex. (A) 
Sedimentation equilibrium was performed with the HIRA/CABIN1 complex, three 
different protein concentrations (0.3, 0.5, 0.7 OD A280) were analyzed for 
equilibrium distribution at three different speeds (4000, 6000, and 9000 RPM). 
These data were fit to the ideal fitting model using the program HeteroAnalysis. 
The ideal fit yielded an experimental molecular weight of 605989 Da, indicating 
this is population may represent a HIRA3/CABIN12 complex.  
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Figure 4.7 – Linear plot of HIRA/CABIN1 sedimentation equilibrium data. 
Representative data for HIRA, CABIN1, and the HIRA/CABIN1 complex at 0.5 
OD and 9000 RPM were compared to predicted curves for threoretical monomer, 
dimer, and trimer for HIRA and CABIN1 alone, as well as HIRA3/CABIN11, 
HIRA3/CABIN12, HIRA3/CABIN13. Theoretical curves were generated using the 
program HeteroAnalysis. To represent the data on a linear scale the curves were 
plotted using a logarithmic normalization.  
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4.3 – HIRA(661-872) and HIRA(905-1017) are tethered for trimer formation 
 
As HIRA(661-1017) is predicted to have a strand region and a helical region, 
which are separated by a relatively unstructured loop (Figure 4.1), we decided to 
perform limited proteolysis in an attempt to potentially narrow down functional 
domains within residues 661-1017. HIRA(661-1017) was incubated with a 1:50 
dilution of 1 mg/ml or 0.1 mg/ml Trypsin, Chymotrypsin, or Glu-C protease for 
either 15 minutes or 1 hour and resolved on a SDS-PAGE gel. The resulting gel 
indicated that both Trypsin and Chymotrypsin were able to cleave HIRA(661-
1017) into two smaller fragments (Figure 4.8). Bands from the gel were analyzed 
by LC/MS-MS and the proteolysis products were shown to represent HIRA(661-
872) and HIRA(905-1017), indicating that the loop spanning residues 873-904 is 
unstructured and susceptible to protease cleavage. Following this observation we 
decided to monitor the interaction between the separate HIRA(661-872) strand 
domain and HIRA(905-1017) helix domain, as HIRA(661-1017) forms a stable 
trimer and these two regions may potentially interact for trimer formation. 
HIRA(661-1017) was incubated with Trypsin and resolved on a Superdex 200 
10/300 GL column in comparison with HIRA(661-872) mixed in a 1:1 ratio with 
HIRA(905-1017) (Figure 4.9). Both experiments show that HIRA(661-872) and 
HIRA(905-1017) do not co-migrate on the column, indicating that the.HIRA(661-
872) strand domain and HIRA(905-1017) helix domain do not interact with each 
other to mediate trimer formation. 
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Figure 4.8 – Limited proteolysis and LC-MS analysis of HIRA(661-1017). 
(Top) HIRA(661-1017) was incubated with protease from either a 1.0 mg/ml or 
0.1 mg/ml stock solution. Sensitivity of HIRA(661-1017) to Trypsin, Chymotrypsin, 
and Glu-C proteases were screened in this way, time points were taken at 15 
minutes and 1 hour of incubation. LC-MS analysis was performed on the digested 
HIRA(661-1017) fragments, results of analysis are indicated on the proteolysis 
gel. (Bottom) Domain architecture for HIRA updated with results from LC-MS 
analysis.   
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Figure 4.9 – Size-exclusion analysis of digested and mixed HIRA C-terminal 
fragments (Left) HIRA(661-1017) was incubated with Trypsin and resolved on an 
s200 10/300 GL column. (Right) HIRA(661-872) and HIRA(905-1017) were 
purified separately and mixed in a 1:1 ratio before resolving on an s200 10/300 
GL column.  
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We performed sedimentation equilibrium analysis on HIRA(661-872), HIRA(905-
1017), as well as an HIRA(661-1017, ∆873-904) where we replaced the HIRA 
873-904 loop with a GSGSGSGSGSGS linker. The resulting data indicate that 
both HIRA(661-872) (Figure 4.10) and HIRA(905-1017) (Figure 4.11) are 
monomers in solution, while HIRA(661-1017, ∆873-904) still forms a trimer 
(Figure 4.12). These data suggest that the individual strand and helical domains 
need to be linked by the 873-904 loop to be able to form the trimer, and replacing 
this loop with another amino acid sequence still allows for trimer formation.  
4.4 – The HIRA/CABIN1 complex is dependent on HIRA trimer formation 
and specific contacts from the HIRA(873-904) loop region 
 
To further elucidate the molecular contacts underlying the HIRA/CABIN1 
complex, we monitored complex formation between CABIN1 FL and HIRA(661-
1017, ∆873-904), HIRA(661-872), and HIRA(905-1017) in comparison with 
HIRA(661-1017). CABIN1 FL was incubated with 5-fold excess HIRA and 
resolved on a Superdex 200 10/300 GL column. We observed that when CABIN1 
FL was incubated with HIRA(661-1017, ∆873-904), HIRA(661-872), and 
HIRA(905-1017) there was no detectable complex formation in comparison with 
HIRA(661-1017) (Figure 4.13). Although it does appear as if some HIRA is 
migrating in the region of CABIN1 for HIRA(661-1017, ∆873-904) and HIRA(661-
872), there does not appear to be complex formation, as the CABIN1 FL band 
had not undergone an increased molecular weight shift. The bands for  
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Figure 4.10 – Analytical ultracentrifugation of HIRA(661-872). (A) 
Sedimentation equilibrium was performed with HIRA(661-872) alone, three 
different protein concentrations (0.3, 0.5, 0.7 OD A280) were analyzed for 
equilibrium distribution at three different speeds (12000, 18000, and 26000 RPM). 
These data were fit to the ideal fitting model using the program HeteroAnalysis. 
The ideal fit yielded an experimental molecular weight of 24189 Da, indicating this 
is population may represent a HIRA(661-872) monomer. 
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Figure 4.11 – Analytical ultracentrifugation of HIRA(905-1017). (A) 
Sedimentation equilibrium was performed with HIRA(905-1017) alone, three 
different protein concentrations (0.3, 0.5, 0.7 OD A280) were analyzed for 
equilibrium distribution at three different speeds (12000, 18000, and 26000 RPM). 
These data were fit to the ideal fitting model using the program HeteroAnalysis. 
The ideal fit yielded an experimental molecular weight of 13351 Da, indicating this 
is population may represent a HIRA(905-1017) monomer. 
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Figure 4.12 – Analytical ultracentrifugation of HIRA(661-1017, ∆873-904). (A) 
Sedimentation equilibrium was performed with HIRA(661-1017, ∆873-904) alone, 
three different protein concentrations (0.3, 0.5, 0.7 OD A280) were analyzed for 
equilibrium distribution at three different speeds (6000, 9000, and 12000 RPM). 
These data were fit to the ideal fitting model using the program HeteroAnalysis. 
The ideal fit yielded an experimental molecular weight of 109780 Da, indicating 
this is population may represent a HIRA(661-1017, ∆873-904) trimer. 
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Figure 4.13 – Size-exclusion analysis of HIRA C-terminal fragments with 
CABIN1. (A) Domain architecture for HIRA. (B) Size-exclusion analysis of 
complex formation between CABIN1 FL and HIRA(661-1017) WT, HIRA(661-
1017, ∆873-904), HIRA(661-872), and HIRA(905-1017). For all runs 5X excess 
HIRA was incubated with CABIN1 FL and resolved on a Superose 6 10/300 GL 
column. Dashed lines represent where CABIN1 FL elutes individually 
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HIRA(661-1017, ∆873-904) and HIRA(661-872) in the vicinity of CABIN1 are also 
present when these fragments are resolved on the column in absence of CABIN1 
FL, indicating that these bands represent a small amount of HIRA aggregation, 
not CABIN1 interaction (Figure 4.14). 
As we observed no complex formation for CABIN1 FL with HIRA(661-1017, 
∆873-904), HIRA(661-872), and HIRA(905-1017), we hypothesized that CABIN1 
may be binding to HIRA in the region of the 873-904 loop. To test this we 
decided to monitor CABIN1 interaction with HIRA(873-1017) to see if the 873-
904 loop alone is sufficient for CABIN1 binding. We also attempted to make 
HIRA(661-904) for this experiment but this HIRA fragment turned out to be 
insoluble and not suitable for biophysical studies (data not shown). We incubated 
HIRA(873-1017) with CABIN1 FL and resolved the mixture on a Superdex 200 
10/300 GL column in comparison with HIRA(661-1017) (Figure 4.15). We 
observed that HIRA(873-1017) was not able to form a complex with CABIN1. 
This indicates that while the presence of the HIRA(873-904) loop is important for 
CABIN1 binding, the interaction is likely dependent on the HIRA trimer in 
combination with the 873-904 loop.  
Based on our observation that HIRA(661-1017, ∆873-904) does not bind 
CABIN1, our collaborators decided to generate some combined alanine point 
mutants in the loop region. They tested interaction of HIRA FL bearing the 
F870A_R871A_L874A mutations with CABIN1 FL and observed that this triple  
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Figure 4.14 – Size-exclusion analysis of HIRA C-terminal fragments. (A) 
Size-exclusion analysis of HIRA(661-1017, ∆873-904) alone. (B) Size-exclusion 
analysis of HIRA(661-872) alone. (C) Size-exclusion analysis HIRA(905-1017) 
alone. All runs were performed on a Superose 6 10/300 GL column.  
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Figure 4.15 – Size-exclusion analysis of HIRA(873-1017) with CABIN1. (A) 
Size-exclusion analysis of HIRA(873-1017) alone. (B) Size-exclusion analysis of 
HIRA(873-1017) with CABIN1 (Top), in comparison with the complex formed 
between HIRA(661-1017) and CABIN1 (Bottom). All runs were performed on a 
Superose 6 10/300 GL column. Dashed lines represent where CABIN1 FL elutes 
individually 
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mutant shows decreased CABIN1 binding similarly to HIRA FL with the 873-904 
loop replaced with the GSGSGSGSGSGS linker (data not shown). We then 
introduced the same F870A_R871A_L874A triple mutant into HIRA(661-1017) 
and monitored complex formation with CABIN in comparison with HIRA(661-
1017) WT (Figure 4.16). In our hands the HIRA F870A_R871A_L874A triple 
mutant showed reduced complex formation with CABIN1, but not a complete 
abrogation of the HIRA/CABIN1 interaction. In comparison with CABIN1 FL run 
alone we observe a very significant larger molecular weight shift with the addition 
of HIRA(661-1017). This shift is not as evident when CABIN1 FL is mixed with 
HIRA(661-1017) F870A_R871A_L874A, although there is still complex formation, 
indicating that the triple mutant decreases but does not ablate CABIN1 
interaction.  
4.5 – HIRA may be structurally homologous to Ctf4 
 
Concurrently with our biochemical investigation into the HIRA/CABIN1 
interaction, we also pursued the X-ray crystal structure of the HIRA trimer alone 
and in complex withCABIN1. Several rounds of crystal screens were set up for 
HIRA(661-1017), HIRA(661-872), HIRA(905-1017), HIRA(661-1017, ∆873-904), 
and the CABIN1/HIRA(661-1017) complex. From all of our attempts we have 
only been able to prepare crystals of HIRA(661-872) (Figure 4.17a). These 
crystals diffract to about 3.5Å (Figure 4.17b), but are sensitive to radiation and 
have relatively low symmetry with a P21 space group. We have collected some  
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Figure 4.16 – Size-exclusion analysis of HIRA(661-1017, F870A_R871A_L874A) 
with CABIN1. Size-exclusion analysis of CABIN1 FL alone (Top), HIRA(661-1017, 
F870A_R871A_L874A) with CABIN1, and HIRA(661-1017) WT with CABIN1 
(bottom). All runs were performed on a Superose 6 10/300 GL column. Dashed lines 
represent where CABIN1 FL elutes individually. 
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Figure 4.17 – Crystallization and X-ray diffraction of HIRA(661-872). (A) Crystals 
formed for HIRA(661-872) in a solution of 10% PEG 6K, 0.1M Tris pH 8.0, and 0.1M 
NaCl. (B) Representative diffraction frame for HIRA(661-872) crystal, data goes to 
roughly 3.5 Å, diffraction data collected at the Advanced Photon Source (APS).   
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datasets for selenomethionine and platinum derived crystals that diffract to about 
3.5Å or 4.0Å, but have yet to determine the structure. 
While attempting to determine the HIRA(661-872)  structure, we submitted the 
sequence for HIRA(661-1017) to the Protein Homology/analogY Recognition 
Engine (Phyre) for structure prediction in attempt to find a molecular replacement 
search model for the crystallographic data. While the Phyre model did not work 
for molecular replacement, it did help us identify a previously uncharacterized 
structural homolog for HIRA. The top hit in the Phyre search was a protein called 
Ctf4, which has function in linking the Cdc45-MCM-GINS (CMG) helicase to DNA 
polymerase alpha, along with other proteins that have been found to harbor a 
CIP-box (Ctf4-interacting-peptide) motif(Villa et al., 2016). Interestingly the C-
terminal region of Ctf4 is also separated into strand and helix domains which 
interact to form a homotrimer (Figure 4.18a) (Simon et al., 2014; Villa et al., 
2016). This is noteworthy, as we have identified another strand/helix trimer 
forming domain, which may be similar to HIRA(661-1017). Ctf4 also harbors an 
N-terminal WD40 domain similar to HIRA, further indicating that these two 
proteins may be distantly related structural homologs (Figure 4.18b). Ctf4 is 
involved in linking several proteins to the CMG complex, containing the histone 
chaperone MCM2, which is involved in H3/H4 shuttling during DNA replication. 
Based on this relation to Ctf4 we hypothesize that HIRA may interact with RNA  
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Figure 4.18 – The HIRA C-terminal strand/helix domain may form a trimer 
similar to Ctf4. (A) 3.0 Å crystal structure for Ctf4(474-927) depicting the formation 
of a homotrimer. (B) Comparison of domain architecture for HIRA and Ctf4 
representing the similarity in the domain organization between the two proteins. (C) 
Remaining Ctf4 crystal structures representing data for the three strand but only two 
helical domain conformation, and Ctf4(3)/Peptide(2) binding stoichiometry for Sld5, 
Pol alpha, and Dna2 peptides.    
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polymerase and potentially other proteins in a similar manner during gene 
transcription, although additional studies are needed to confirm this prediction. 
Of particular interest is that of the six crystal structures deposited into the PDB 
for the Ctf4 C-terminal trimer, only one structure has density for all three helical 
domains (4C8H) (Figure 4.18a). All five remaining structures have three strand 
domains, but only two helical domains resolved (5HOG, 5HOI, 4C8S, 4C93, 
4C95) (Figure 4.18c). One of these is of the Ctf4 trimer alone (4C8S), while the 
other four depict a Ctf4 trimer associated with Ctf4-interacting peptides from 
either Pol alpha, Sld5, Dna2, or Tof2. The structures for Ctf4 bound to Pol alpha, 
Sld5, and Dna2 have a Ctf4(3)/Peptide(2) stoichiometry with the peptide 
associated with the helical region of Ctf4, while the structure for Ctf4 bound to 
Tof2 has a Ctf4(3)/Peptide(3) stoichiometry and the Tof2 peptide is bound to the 
cleft between the strand and helical regions of Ctf4. We have identified that the 
loop separating the stand and helical domains for HIRA is essential for CABIN1 
interaction, the HIRA(3)/CABIN1(2) stoichiometry we have observed may be 
related to how Ctf4 interacts with some of its binding partners using a 3:2 
stoichiometry. 
4.6 – Hir1/Hir2 from S. cerevisiae associate to form a heterotrimer 
 
An interesting note on the observed HIRA(3)/CABIN1(2) stoichiometry may be 
gleaned from the Hir complex in S. cerevisiae, where two proteins called Hir1 
and Hir2 work together to form a functional HIRA unit. It has been reported that 
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the Hir complex harbors two copies of Hir2 and one copy of Hir1(Prochasson et 
al., 2005). Both Hir1 and Hir2 are homologous to HIRA residues 1-858; the Hir1 
C-terminus corresponds to HIRA residue 1-858, while only Hir2 harbors 
sequence homologous to HIRA residues 859-1017 harboring both the loop and 
the helical regions (Figure 4.19). It is possible that the HIRA(3)/CABIN1(2) 
stoichiometry is an evolutionary holdover from yeast where the complex did not 
have three binding sites for the CABIN1 homolog Hir3. To address this 
hypothesis we prepared the representative C-terminal regions for Hir2 alone and 
a complex of Hir1/Hir2 from co-expression in E. coli (Figure 4.20a). We were 
unable to produce soluble Hir1 when it was expressed alone. We used 
sedimentation equilibrium to analyze the stoichiometry of our Hir2 and Hir1/Hir2 
complex and showed that Hir2 alone exists as a dimer, and forms a heterotrimer 
when co-expressed with Hir1, presumably with a stoichiometry of Hir2(2)/Hir1(1)  
(Figure 4.20b). We attempted to prepare a complex between Hir1/Hir2 and Hir3, 
although we were unable to prepare soluble Hir3 in bacteria and insect cells. 
With evidence from Ctf4 and the yeast Hir complex, the HIRA trimer and the 
HIRA(3)/CABIN1(2) stoichiometry likely represent biologically relevant 
confirmations. 
4.7 – Discussion 
 
Although our studies into HIRA timer formation and the HIRA/CABIN1 complex 
are incomplete, we have been able to characterize several previously unknown  
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Figure 4.19 – Alignment of HIRA homologs. Multiple sequence alignment 
showing conservation among Homo sapiens HIRA, Mus musculus HIRA, Xenopus 
laevis HIRA, Danio rerio HIRA, Drosophila melanogaster HIRA, Caenorhabditis 
elegans HIRA, Saccharomyces cerevisiae Hir1, and Saccharomyces cerevisiae 
Hir2. Alignment contains residues corresponding to human HIRA residues 677-
1017.  
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Figure 4.20 – Preparation of the Hir1/Hir2 complex. (A) Ion exchange and size-
exclusion purification of the C-terminal regions of Hir2 alone and the Hir1/Hir2 
complex. (B) Sedimentation equilibrium analysis of Hir2 alone and the Hir1/Hir2 
complex, experimental data in comparison with predicted theoretical data.  
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aspects of how the HIRA C-terminal domain functions to form a homotrimer 
which is essential for binding with CABIN1. We have shown that the HIRA(661-
1017) is organized into separate strand (HIRA(661-872)) and helical (HIRA(905-
1017)) domains which are tethered by a loop spanning HIRA residues 873-904. 
We have shown that the strand and helical domains must be tethered by a linker 
for proper trimer formation, although the sequence of the linker is not important 
for formation of the trimer. Additionally we have shown that formation of the 
HIRA/CABIN1 complex is dependent on the HIRA trimer as well as the proper 
sequence of the HIRA(873-904) loop, as deletion or mutagenesis of the loop 
decreases formation of the complex. Finally we have shown that HIRA may be 
structurally homologous to the protein Ctf4, which has very similar domain 
organization to HIRA and has also been shown to form a homotrimer. 
A crystal structure for the HIRA C-terminal region would help us further 
understand the nature of the HIRA trimer and to determine if it does indeed form 
a structure similar to Ctf4. While we have focused on HIRA(661-872) as we have 
been able to produce crystals for this fragment, it may not yield structural 
information into the molecular contacts required for trimer formation, as 
HIRA(661-872) exists as a monomer in solution. We plan to focus on further 
crystal screening for HIRA(661-1017) as well as HIRA(661-1017, ∆873-904) and 
potentially other variants of the loop deletion as there is no density for the 
homologous loop spanning residues 796-814 in Ctf4 (Simon et al., 2014). We 
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have reinforced our data demonstrating the HIRA trimer and HIRA(3)/CABIN1(2) 
stoichiometry with biological evidence from Ctf4 and the yeast Hir complex, 
although it is unclear why this complex would need to form a trimer to carry out 
the function of depositing an (H3.3/H4)2 tetramer into chromatin. As we have 
discussed extensively in chapter 3, UBN1 may form a dimer to allow formation of 
an (H3.3/H4)2 heterotetramer from two ASF1a bound H3.3/H4 heterodimers. If 
we combine the idea of two UBN1 molecules bound to a (H3.3/H4)2 tetramer, 
associated with a trimer of HIRA, it is possible that a HIRA complex with a third 
UBN1 molecule harboring an ASF1a/H3.3/H4 unit is held in reserve to be 
transferred into the next (H3.3/H4)2 tetramer to be formed for deposition (Figure 
4.21). This idea of a histone reservoir may be difficult to test biochemically, 
although we plan to use an electron microscopy based approach to investigate 
the structural confirmation of the full-length HIRA complex. We believe these 
structural studies may help confirm the molecular assembly of the full-length 
HIRA complex associated with histones and ASF1a. Although further studies are 
needed to elaborate on the observations we have presented here. Our 
investigation has characterized the previously unknown HIRA trimer, and further 
elucidated the molecular contacts underlying the HIRA/CABIN1 complex. 
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Figure 4.21 – Model for molecular assembly of the HIRA complex. Depiction of 
the HIRA complex showing a HIRA(3)/UBN1(3)/CABIN1(2) stoichiometry. The 
UBN1 NHRD is shown in green while the orange domain represents the UBN1 
HRD and middle domain as they both may contribute to (H3.3/H4)2 tetramer 
binding. 
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4.8 – Materials and methods 
 
Multiple sequence alignments. Alignment for Figures 4.19 was generated 
using Clustal Omega (Sievers et al., 2011), and formatted for better visualization 
using ESPript version 3.0 (Gouet et al., 2003).  
Protein secondary structure prediction. Predicted secondary structure of 
HIRA depicted in Figure 4.1 was generated using the PSIPRED secondary 
structure prediction server (Buchan et al., 2013).  
Generation of expression plasmids. The plasmids encoding GST-HIRA(661-
1017), GST-HIRA(661-872), GST-HIRA(905-1017), and GST-HIRA(873-1017) 
and were generated by PCR amplification from a FL HIRA construct (Banumathy 
et al., 2009; Tang et al., 2012) and ligation into the EcoRI/XhoI sites of a custom 
engineered pRSFduet-1 (Novagen) Escherichia coli expression vector carrying a 
N-terminal GST tag that is removable by TEV protease cleavage. The plasmids 
encoding GST-HIRA(661-1017, D873-904) and GST-HIRA(661-1017) 
F870A_R871A_L874Awere generated by site-directed mutagenesis(Weiner 
and Costa, 1994). The plasmids encoding FL H3.1, H3.3, and H4 were 
generated as described previously (Ricketts et al., 2015). The plasmid encoding 
FL His-CABIN1 was generated as described previously (Rai et al., 2011; Ricketts 
et al., 2015; Tang et al., 2012). The plasmid encoding GST-Hir1(599-840) was 
generated by PCR amplification and ligation into the EcoRI/XhoI sites of a 
custom engineered pRSFduet-1 (Novagen) Escherichia coli expression vector 
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carrying a N-terminal GST tag that is removable by TEV protease cleavage. The 
plasmid encoding His-Hir2(471-875) was generated by PCR amplification and 
ligation into the EcoRI/XhoI sites of a custom engineered pETduet-1 (Novagen) 
Escherichia coli expression vector carrying a N-terminal His tag that is removable 
by TEV protease cleavage. 
Protein expression and purification. H3.3 and H4 individual histone proteins 
were expressed to the inclusion bodies in BL21-Gold(DE3) cells (Agilent). The 
individual histone proteins were purified and refolded to form H3.3/H4 as 
previously described (Luger et al., 1999; Ricketts et al., 2015). GST-HIRA(661-
1017), GST-HIRA(661-872), GST-HIRA(905-1017), GST-HIRA(873-1017), GST-
HIRA(661-1017, D873-904) and GST-HIRA(661-1017) F870A_R871A_L874A 
were generated in BL21-Gold(DE3) cells (Agilent) induced with 0.8 mM IPTG and 
expressed overnight at 18°C. Cells were re-suspended in 1XPBS supplemented 
with 5 mM BME and lysed by sonication. Lysate was clarified by centrifugation 
and supernatant was subjected to GST affinity chromatography. The GST-
Hir1(599-840)/His-Hir2(471-875) complex was co-expressed and subjected to 
GST affinity chromatography similar to the GST-HIRA fragments. GST fusion 
proteins were then subjected to on-column cleavage overnight though incubation 
with TEV protease. Proteins were then eluted into buffer containing 20 mM Tris 
pH 8.0, 50 mM NaCl, and 5 mM BME. Proteins were then subjected to ion 
exchange chromatography using a HiTrap Q column (GE Healthcare). Following 
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ion exchange, proteins were concentrated using a spin concentrator (Millipore) 
and loaded onto a Superdex 200 10/300 GL or Superose 6 10/300 GL (GE 
Healthcare) column for further purification by size-exclusion in a buffer containing 
20 mM Tris pH 8.0, 300 mM NaCl, and 1 mM TCEP. His-Hir2(471-875) alone 
was generated in BL21-Gold(DE3) cells (Agilent) induced with 0.8 mM IPTG and 
expressed overnight at 18°C. Cells were re-suspended in buffer containing 20 
mM Tris pH 8.0, 500 mM NaCl, 5 mM BME, and 10 mM imidazole and lysed with 
sonication. Lysate was clarified with centrifugation and the supernatant was 
subjected to nickel affinity chromatography to isolate the His tagged protein. 
Protein was eluted with 200 mM Imidazole and dialyzed overnight with the 
addition of TEV protease to remove the His tag, dialysis buffer contains 20 mM 
Tris pH 8.0, 50 mM NaCl, and 5 mM BME. Protein was then subjected to ion 
exchange chromatography using a HiTrap Q column (GE Healthcare) followed by 
size-exclusion on an s200 10/300 GL or Superose 6 10/300 GL column in buffer 
containing 20 mM Tris pH 8.0, 300 mM NaCl, and 1 mM TCEP. His-CABIN1 was 
generated through expression in Sf9 cells as described previously (Rai et al., 
2011; Ricketts et al., 2015). Cells were re-suspended in buffer containing 20 mM 
Tris pH 8.0, 500 mM NaCl, 5 mM BME, and 10 mM imidazole and lysed with 
sonication. Lysate was clarified with centrifugation and the supernatant was 
subjected to nickel affinity chromatography to isolate the His tagged protein. 
Protein was eluted with 200 mM Imidazole and dialyzed overnight into buffer with 
20 mM Tris pH 8.0, 300 mM NaCl, 1 mM TCEP. Protein was then concentrated 
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using proteins were concentrated using a spin concentrator (Millipore) and 
resolved on a Superose 6 10/300 GL column in a buffer with 20 mM Tris pH 8.0, 
300 mM NaCl, 1 mM TCEP. 
Assembly of HIRA/CABIN1 complexes using size-exclusion 
chromatography. To form complexes of HIRA and CABIN1, HIRA was 
incubated in a five-fold molar excess with CABIN1, generally about 100 µM HIRA 
incubated with 20 µM CABIN1. The complex was allowed to incubate at 4°C for 
30 minutes prior to resolving on a Superose 6 10/300 GL column in a buffer 
containing 20 mM Tris pH 8.0, 300 mM NaCl, and 1 mM TCEP. For the 
experiment where HIRA(661-872) was resolved with HIRA(905-1017) on a s200 
10/300 GL column, both fragments were incubated together at 50 µM prior to 
resolving on the column in a buffer containing 20 mM Tris pH 8.0, 300 mM NaCl, 
and 1 mM TCEP. 
Analytical ultracentrifugation – sedimentation equilibrium. HIRA, CABIN1, 
Hir2, Hir1/Hir2, or the HIRA/CAIBN1 complex eluting from the size-exclusion 
column was then pooled and analyzed for concentration. Samples were prepared 
at roughly 0.3, 0.5, and 0.7 OD 280 nm, loaded into a 6-channel 
ultracentrifugation cell with buffer blanks, and analyzed for equilibrium distribution 
analysis several speeds using an Optima XL-I analytical ultracentrifuge 
(Beckman). Equilibrium distribution data were fit with the program HeteroAnalysis 
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using the ideal fitting model (Cole, 2004). Global fits were conducted using three 
centrifugation speeds and three protein concentrations.  
Limited Proteolysis. HIRA 661-1017 was held at a concentration of 1 mg/ml 
and incubated with a 1:50 dilution of either 1 mg/ml or 0.1 mg/ml Trypsin, 
Chymotrypsin, or Glu-C protease. The proteolysis was monitored by SDS-PAGE 
gel visualization at 15 minutes and 1 hour of incubation. The resulting proteolysis 
products observed on the gel were then analysis by LC/MS-MS with the aid of 
the Proteomics and Metabolomics Facility. For size-exclusion analysis of 
HIRA(661-1017) incubated with Trypsin, 500 µL of HIRA(661-1017) at 1 mg/ml 
was incubated with 10 µl of 0.1 mg/ml Trypsin for 30 minutes before resolving the 
mixture on an s200 10/300 GL column in a buffer with 20 mM Tris pH 8.0, 300 
mM NaCl, and 1 mM TCEP.  
Crystallization and X-ray diffraction. Crystals of HIRA(661-872) were initially 
grown by hanging drop vapor diffusion with a solution of 0.1 M HEPES pH 7.5, 
10% PEG 4K, and 0.1 MgCl2. Although these crystals did not show any evidence 
of X-ray diffraction we used them for microseeding trials. Crystals were harvested 
in the well solution and crushed into microseeds with the use of a Seed Bead 
(Hampton Research). Microseeds were then added to crystal drops across a new 
series of sparse matrix seeding in attempt to identify new crystal conditions. The 
largest seeded crystals of HIRA(661-872) grew with a well solution containing 0.1 
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M Tris pH 8.0, 10% PEG 6K, and 0.1 M NaCl. We were able to collect diffraction 
data from these seeded crystals.  
Ctf4 structural models. Representative models of the Ctf4 trimer alone and 
bound to peptide were formatted for display using The PyMOL Molecular 
Graphics System, Version 1.8 Schrödinger, LLC. 
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CHAPTER 5:  Conclusions and Future Directions 
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5.1 – Overview 
 
Through these studies we have identified several previously unknown functions 
of the HIRA complex and proposed how our observations are likely involved in 
the mechanism of H3.3/H4 deposition by the HIRA complex. In this chapter we 
summarize our findings and propose additional studies to expand upon these 
discoveries.  
5.2 – Ubinuclein-1 confers histone H3.3 binding specificity by the HIRA 
histone chaperone complex 
 
When we initially set out to identify the molecular basis for H3.3/H4 deposition by 
the multi-protein HIRA histone chaperone complex it was clear that the three 
proteins HIRA, UBN1, and CABIN1 cooperated with ASF1a to facilitate 
deposition of H3.3/H4 into nucleosomes, although it was unclear how this 
complex was able to specifically binds to and deposit H3.3/H4 over the highly 
homologous H3.1/H4 where H3.3 and H3.1 differ by only five amino acids.  
The general feeling in the field at the time that we started this project was that the 
protein HIRA likely mediated H3.3/H4 binding and deposition with the aid of 
UBN1, CABIN1, and ASF1a, as HIRA had been the focus of many of the initial 
studies into this multi-subunit histone chaperone complex ((Loppin et al., 2005; 
Ray-Gallet et al., 2002; Ray-Gallet et al., 2007; Tang et al., 2006; Zhang et al., 
2005). More recently the protein UBN1 has been identified as a homolog of the 
yeast Hir complex subunit Hpc2 though conservation in the highly acidic HRD 
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domain. It was initially suspected that the HRD was responsible for binding with 
HIRA(Banumathy et al., 2009), although we later identified a domain N-terminal 
to the HRD that was essential and sufficient for HIRA binding which we named 
the NHRD(Tang et al., 2012).  
Following the discovery of the less conserved NHRD domain, we then focused 
our efforts on identifying if the acidic UBN1 HRD was able to bind H3.3/H4, as 
histone chaperones have long been known to harbor acidic regions to interact 
with the highly basic histone proteins(Laskey et al., 1978). We were able to 
express and purify the UBN1 HRD and show that it bound to H3.3/H4 with 
specificity over H3.1/H4 in the presence or absence of the HIRA N-terminal 
WD40 domain in a GST pull-down histone-binding assay. The UBN1/H3.3/H4 
interaction was then quantified by ITC and a fluorescence polarization binding 
assay, UBN1 bound to H3.3/H4 with a Kd in the low micromolar range while we 
were not able to quantify interaction with H3.1/H4. We then went on to show that 
highly conserved residues in the UBN1 HRD were essential for H3.3/H4 binding 
as mutation of these residues to alanine abrogated the UBN1/H3.3/H4 interaction 
by GST pull-down and in a fluorescence polarization histone-binding assay. We 
then used mutagenesis to probe the five differing amino acids between H3.1 and 
H3.3 and demonstrated with GST pull-down and ITC that UBN1 recognizes the 
AAIG patch spanning residues 87-90 in H3.3 with G90 contributing the most to 
the specificity of UBN1 binding. 
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At this point we had spent significant time and effort trying to crystallize the UBN1 
bound to H3.3/H4 alone, so we decided to us the previously crystalized 
H3/H4/Asf1 complex as a staring point to help us determine a 2.3Å crystal 
structure of UBN1 HRD residues 122-142 bound to H3.3/H4/Asf1. Our structure 
revealed that conserved UBN1 HRD residues sensitive to alanine mutagenesis 
are involved in key contacts between UBN1 and H3.3/H4 in the vicinity of the 87-
90 AAIG patch on the H3.3 surface, confirming the veracity of our biochemical 
results. From our structure we also observed that UBN1 and the unrelated 
H3.3/H4 chaperone Daxx bind to the H3.3/H4 surface in the region of the AAIG 
patch with surprising similarity of structure, even though there not sequence 
conservation between UBN1 and Daxx and they actually bind to the histones with 
differing N to C-terminal orientation. The similarity in how UBN1 and Daxx bind to 
the H3.3/H4 surface represents the evolutionary importance of H3.3/H4; as these 
are two seemingly un-related histone chaperones that target differing areas of 
chromatin for H3.3/H4 deposition.  
Finally we have demonstrated that mutation of critical HRD residues abrogates 
the ability of the full-length HIRA complex to bind to H3.3/H4 with specificity over 
H3.1/H4, indicating that binding by the UBN1 HRD is essential for H3.3/H4 
specific binding. It is worth noting that while the region of Daxx we have 
discussed shows similarity to how the UBN1 HRD associates with H3.3/H4, the 
determined crystal structures of Daxx/H3.3/H4 contain a much larger fragment of 
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Daxx (residues 182-386) which form a large helical structure that full 
encompasses an H3.3/H4 dimer with many points of contact on the H3.3/H4 
surface (Elsasser et al., 2012; Liu et al., 2012). From this, evidence form the full-
length HIRA complex, and our observations that flanking regions of the UBN1 
HRD (residues 92-121 and 149-175) also contribute to histone binding, we 
hypothesize that additional regions of UBN1, with potential contribution from 
other HIRA complex subunits, likely associate to form a larger complex with 
additional H3.3/H4 contacts in comparison with what we have observed in our 
UBN1(122-142)/H3.3/H4/Asf1 structure. Although our pull-down results with the 
full-length HIRA complex clearly demonstrate that the UBN1 HRD is essential for 
H3.3/H4 binding specificity. 
Although, the mechanism for how the HIRA complex actually incorporates 
H3.3/H4 into nucleosomes likely involves additional steps beyond the specific 
binding to H3.3/H4 that we have demonstrated. To expand upon current 
understanding of how the HIRA complex specifically deposits H3.3/H4 into 
chromatin we set to characterize additional regions of the UBN1. 
5.3 – The HIRA histone chaperone complex subunit UBN1 harbors H3/H4 
and DNA binding activity 
 
Following our discovery of H3.3/H4 specific binding activity by the UBN1 HRD, 
we then decided to characterize additional regions of UBN1 as it is a very large 
protein with only the two small NHRD and HRD domains studied in any detail. As 
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discussed above we were primarily interested in investigating if UBN1 harbored 
any additional regions with H3.3/H4 binding activity. We also suspected based on 
previous evidence that UBN1 may be able to bind DNA (Ray-Gallet et al., 2011). 
We performed alignment and secondary structure predication and identified a 
conserved and structured region roughly spanning residues 300-600 as a starting 
point for our functional characterization. Due to the roughly central location of this 
region within the UBN1 sequence we have titled this the UBN1 middle domain. 
We initially showed that the middle domain fragment UBN(296-584) resolves into 
two peaks on a size-exclusion column and employed sedimentation equilibrium 
analysis to show that these peaks represent static monomer and dimer 
populations. We found this of great interest as it has been reported that the 
majority of H3.3/H4 is deposited into nucleosomes in the (H3.3/H4)2 tetramer 
confirmation. Additionally we have previously observed with ITC conduced with 
the UBN1 HRD peptide and H3.3/H4 in the absence of Asf1, that UBN1 interacts 
with H3.3/H4 in a 1:1 ratio. This result could be interpreted as a 1:1:1 
UBN1/H3.3/H4 complex, although it is more likely that this represents a 2:2:2 
UBN1/H3.3/H4 complex as H3.3/H4 have been reported to exist as a tetramer at 
the concentrations at which we conduced ITC(Winkler et al., 2012). If we 
combine our observation of UBN1 dimer formation with these existing data a 
hypothesis for a model of HIRA complex function emerges where UBN1 forms a 
dimer to associate with a H3.3/H4 tetramer. We then showed that the C-terminal 
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region of the middle domain (residues 504-584) is essential for formation of the 
dimer population, while residues 296-341 are dispensable.  
Next we identified that the UBN1 middle domain also has histone binding activity 
with no specificity towards H3.3/H4 over H3.1/H4, although it does appear to be 
specific to H3/H4 and does not bind H2A/H2B. This interaction seems to be 
driven by electrostatics as the middle domain binds to H3/H4 well at 300 mM 
NaCl, but the interaction is abated when the pull-down was conducted with 750 
mM NaCl. We then showed that UBN1 residues 504-584 are dispensable for 
H3/H4 binding while deletion of residues 296-341 abolishes the interaction 
between the UBN1 middle domain and H3/H4. We then made a series of 
deletions across residues 296-341 each of which showed a gradual reduction in 
H3/H4 binding indicating that several residues in this region are involved in 
binding to the histones. Finally we tested the interaction of the UBN1 middle 
domain with full-length H3/H4 and H3/H4 with the N-terminal tails removed. We 
demonstrated that the middle domain binds to full-length H3/H4 well but shows 
greatly reduced binding with the tailless H3/H4 indicating that the UBN1 middle 
domain interacts with the charged N-terminal H3/H4 tails.  
The UBN1 HRD and middle domain are separated by a highly basic linker region, 
which harbors many lysine residues that are conserved among vertebrate UBN1 
homologs. It had been previously reported that UBN1 was able to nonspecifically 
bind DNA with greater affinity than HIRA or CABIN1. We hypothesized that 
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UBN1 DNA binding activity may be mediated by this highly basic linker region 
spanning UBN1 residues 176-295. To address this hypothesis we tested the 
ability of UBN1 to bind DNA using a fluorescence polarization assay and 
demonstrated that WT UBN1 is able to bind DNA with nanomolar affinity, and if 
we delete UBN1 residues 176-295 and replace them with a poly glycine serine 
linker UBN1 is no longer able to form complex with DNA. We then made a series 
of targeted deletions of individual patches of lysine residues within this UBN1 
region and showed that removal of these residues decreases the binding affinity, 
from which we can conclude that these conserved lysine residues are involved in 
a non-specific electrostatic DNA binding activity.  
As UBN1 needs to deposit H3.3/H4 into chromatin it is highly intriguing that 
UBN1 harbors a DNA binding domain directly between adjacent histone binding 
domains. From this discovery we developed a hypothesis for H3.3/H4 deposition 
that involved histone binding, dimer formation to induce formation of an 
(H3.3/H4)2 tetramer, and DNA binding activity by UBN1. We then investigated if 
the UBN1 HRD and middle domain could cooperate to bind H3.3/H4 together in 
formation of a larger chaperone/histone complex. We analyzed the contribution 
of both the UBN1 middle domain dimer and monomer populations to binding with 
H3.3/H4 and observed that the UBN1 HRD and middle domain compete for 
H3.3/H4 binding and associate with the histones in a mutually exclusive manner. 
Finally we investigated the ability of UBN1 to bind free H3.3/H4 in comparison 
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with assembled nucleosomes. We discovered that UBN1 fragments as large as 
UBN1(122-584) were capable of binding to free H3.3/H4 with no detectable 
interaction with the nucleosome. Indicating that UBN1 is likely involved in 
chaperoning free H3.3/H4 for nucleosome assembly. 
From our observations we proposed a multi-step model for H3.3/H4 deposition 
by the HIRA complex involving a handoff of H3.3/H4 between the HRD and 
middle domain and DNA binding. So far it is unclear what the exact order of 
these events may be and our proposed model represents just one possible 
scenario. It is likely that yet to be determined cellular events also contribute to 
this multi-step process, one outstanding detail is how ASF1a disassociates to 
allow for the proposed formation of the (H3.3/H4)2 tetramer. We have yet to be 
able to demonstrate the handoff of histones between ASF1a and the HIRA 
complex biochemically. It is possible that a yet to be determined cellular factor 
allows for the release of ASF1a to allow for formation of the (H3.3/H4)2 tetramer. 
ASF1a binds very tightly to the HIRA B-domain, and we have yet to find 
conditions that allow it to dissociate from HIRA or H3.3/H4 (data not shown). To 
address the remaining questions associated with our proposed model for 
H3.3/H4 deposition by the HIRA complex, we plan to pursue electron microscopy 
studies with the full-length HIRA complex with the addition of ASF1/H3.3/H4, 
DNA, or both to identify potentially allosteric structural changes that occur upon 
binding of these factors. Although it is possible that cellular factors such as yet to 
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be discovered PTMs to the HIRA complex, ASF1a, or H3.3/H4 allow for 
transitions between these pre-deposition conformations, which would be more 
difficult to pin down without additional cellular studies to identify potentially 
important PTMs.  
5.4 – Molecular characterization of HIRA oligomer formation and interaction 
with CABIN1 
 
Concurrently with our studies into the UBN1 middle domain and DNA binding 
loop, we began to investigate a link between HIRA oligomer formation and 
binding with the subunit CABIN1. Another group observed that deletions within 
the HIRA C-terminal region reduced the ability of HIRA to both bind CABIN1 and 
pull-down a differentially tagged HIRA. We were invited to collaborate on 
biochemical and biophysical analysis of their findings. We were highly intrigued 
by this as we were already working on the UBN1 middle domain dimerization and 
found it interesting that HIRA may also have oligomer formation activity, which 
would contribute well to our proposed model for HIRA complex function.  
We were able produce a soluble fragment of the HIRA C-terminal domain, 
HIRA(661-1017) which is predicted to be organized into a strand and helical 
region separated by a short linker region. This region of HIRA has been 
previously reported to associate with H3.3/H4 with increased affinity for H3.3/H4 
bearing an S47 phosphorylation(Kang et al., 2011), although we were unable to 
observe any binding with our un-phosphorylated H3.3/H4. From this result it is 
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worth noting that the only histone biding activity we have observed from the 
HIRA-complex subunits we have been able to produce comes from the UBN1 
HRD and middle domain. From our studies both this HIRA C-terminal region and 
the N-terminal WD40 domain of HIRA appear to be dispensable for binding with 
H3.3/H4.  
Using size-exclusion chromatography we were able to show that HIRA(661-
1017) readily forms a complex with full-length CABIN1. To analyze the molecular 
assembly of HIRA alone in comparison with the HIRA/CABIN1 complex we 
performed sedimentation equilibrium analysis on both HIRA(661-1017) and 
CABIN1 alone as well as the complex. We found that HIRA(661-1017) forms a 
stable trimer in isolation while CABIN1 exists as a monomer. Analysis of the 
HIRA/CABIN1 complex revealed that it has a HIRA(3)/CABIN1(2) stoichiometry.  
Limited-proteolysis experiments revealed that the HIRA(661-1017) region is likely 
organized into a HIRA(661-872) strand domain and a HIRA(905-1017) helical 
domain which exist as monomers individually and do not form a complex when 
mixed. Although we were able to replace the 873-905 loop with a GS linker to 
generate HIRA(661-1017, ∆873-905) which still formed a stable trimer. From this 
we concluded that the HIRA(873-904) linker is necessary to bring these domains 
together in the proper conformation for trimer formation.  
Interestingly neither HIRA(661-872), HIRA(905-1017), HIRA(661-1017, ∆873-
905), or even HIRA(873-1017) were able to bind CABIN1, which suggests that 
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the HIRA(873-904) loop is critical for CABIN1 binding but not sufficient without 
HIRA trimer formation. We then went on to show that a triple mutant in the loop 
region, HIRA(661-1017) F870A_R871A_L874A, displayed decreased complex 
formation with CABIN1 further verifying the CABIN1 likely binds in the region of 
the HIRA(873-904) loop.  
We are particularly interested in identifying the amino acid contacts which allow 
for HIRA trimer formation and have extensively attempted crystal screening for 
both HIRA(661-1017) and HIRA(661-1017, ∆873-905) although we have not had 
any hits for either. Although it forms a monomer we have also pursued 
crystallization of HIRA(661-872) which has yielded several hits. We collected 
multiple 3.5-4.0Å datasets for these crystals but have so far been unable to solve 
the structure. Future directions for crystallization include continued optimization 
of these HIRA(661-872) crystals as well as continued attempts with HIRA(661-
1017, ∆873-904) and potentially variations on the length of the GS linker which 
we have replaced the loop with as well as variations on the HIRA residues we 
are removing in this region. 
In attempt to identify a good molecular replacement search model we used the 
Phyre server to predict a model for HIRA(661-872), and to our surprise the top hit 
was a protein called Ctf4 which has remarkably similar domain architecture to 
HIRA. The C-terminal strand/helix domain in Ctf4 also forms a trimer, of which 
there have been 6 different crystal structures reported. Of the six structures only 
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one has density for all three helical domains, and of 4 structures in complex with 
binding partners, 3 have a Ctf4(3)/Peptide(2) stoichiometry. These observations 
about the arrangement of the Ctf4 trimer and the peptide binding stoichiometry 
are potentially crystallographic artifacts, but the similarity to the HIRA trimer and 
HIRA/CABIN1 interaction is very interesting. It is possible that HIRA and Ctf4 are 
distantly related structural homologs and could function in the same way to 
associate with binding partners in a 3:2 stoichiometry.  
An interesting note in comparison of our HIRA(661-1017) trimer is that the Ctf4 
trimer that crystallized is composed of Ctf(474-927) with no loop deletion 
(although there is not density for the loop in any of the published structures). The 
Ctf4 trimer is composed of an additional 97 residues that reside in the N-terminal 
region of the Ctf4 strand domain. Although HIRA has little predicted structure in 
the region of HIRA(564-661), if would be interesting to generate a HIRA(564-
1017) to be of comparable length to the Ctf4 trimer crystallized. It is possible that 
these residues, which are predicted to be unstructured, could contribute to the 
strand domain fold and allow for a more stable HIRA trimer for crystallization 
trials.  
We then turned our focus onto the yeast Hir complex where functional HIRA is 
composed of two homologous proteins called Hir1 and Hir2. Hir1 and Hir2 have 
been reported to associate in a Hir1(1)/Hir2(2) ratio, and only Hir2 has sequence 
homologous to HIRA(873-1017). From this we hypothesized that the HIRA trimer 
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and the odd HIRA(3)/CABIN1(2) binding ratio could also be represented in the 
Hir complex by a Hir1(1)/Hir2(2)/Hir3(2) complex. We were able to produce a 
complex of Hir1 and Hir2 and showed that they do indeed for a Hir1(1)/Hir2(2) 
trimer although we still need to investigate the assembly of the Hir1/Hir2/Hir3 
complex. Although we have had difficulty producing soluble Hir3 this remains an 
important future experiment to further validate our findings about how the 
HIRA/CABIN1 complex assembles and is possibly related to Ctf4 structure and 
function. Additionally we could attempt to see if human CABIN1 will associate 
with the Hir1/Hir2 complex we have produced, as our human CABIN1 expresses 
well in Sf9 cells. Although this may not work, while Hir3 and CABIN1 are 
organized into similar TPR repeat structures, there is little sequence conservation 
between the two homologs(Rai et al., 2011).  
Finally we have combined our observations of a HIRA(3)/CABIN1(2) complex 
with our previously presented hypothesis that UBN1 dimerization may facilitate 
formation of a (H3.3/H4)2 tetramer to propose a new model for assembly of the 
HIRA complex. This model has a HIRA trimer associated with two molecules of 
CABIN1 while each HIRA trimer is bound by UBN1. Of the three UBN1 
molecules we propose that two may form a dimer that associates with an 
(H3.3/H4)2 tetramer, while the third is waiting in the wings with H3.3/H4/ASF1a 
to be incorporated into the next tetramer to be formed for deposition.  
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To verify this model we are optimizing production of the full-length HIRA complex 
in Sf9 insect cells to be used in AUC experiments to study the molecular 
assembly of the full-length complex to compliment our studies with the UBN1 and 
HIRA fragments. In addition to AUC studies with the full length HIRA complex we 
also plan to study the full-length HIRA complex using an electron microscopy 
based approach to further understand the molecular assembly of the full complex 
as well as any structural rearrangement that may occur upon the addition of 
ASF1a/H3.3/H4 and DNA.  
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